###################################################################################################################################################################
#Enrichment results using 'Biological Process from Gene Ontology (GO)', created by dcGO Enrichment at 11/08/2016 18:58:14 (day/month/year hour:min:sec)
#Citation: Fang H, Gough J. (2012) dcGO: database of domain-centric ontologies on functions, phenotypes, diseases and more. Nucleic Acids Res (PubMed ID: 23161684)
###################################################################################################################################################################
#
#'GroupID' column: group id (by default 'Group' for single group);
#'GO ID' column: the identifier of ontological terms;
#'GO term' column: the name of ontological terms;
#'xxxx (four levels)' column: term specificity (only appear when using slim version of the ontology; 1 for highly general, 2 for general, 3 for specific, and 4 for highly specific);
#'Z-score' column: Z-score being calculated based on hypergeometric distribution;
#'P-value' column: P-value being calculated based on hypergeometric distribution;
#'FDR' column: FDR used to assess the statistical significance of term enrichments;
#'#Domains (Overlaps|Group|Term|Background)' column: the number of domains, i.e., 'Overlaps' for the number of domains in the input group but also being annotated by the term; 'Group' for the number of domains in the input group (also annotatable by the ontology); 'Term' for the number of domains being annotated by the term; 'Backgroud' for the number of domains that are annotatable by the ontology.
#'Annotated domains' column: a list of semicolon-separated domains in the input group but also being annotated by the term.
#
GroupID	GO ID	GO term	PFAM slim (four levels)	Z-score	P-value	FDR	#Domains (Overlaps|Group|Term|Background)	Annotated domains
Group	GO:0023051	regulation of signaling	1	11.55	2.91e-23	2.30e-20	89|248|441|3527	PF00019;PF00027;PF00040;PF00041;PF00049;PF00054;PF00057;PF00090;PF00093;PF00096;PF00102;PF00122;PF00130;PF00169;PF00179;PF00200;PF00240;PF00249;PF00341;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00625;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF01030;PF01064;PF01369;PF01391;PF01403;PF01417;PF01437;PF01448;PF01585;PF01699;PF01753;PF01833;PF01843;PF02037;PF02145;PF02148;PF02177;PF02204;PF02210;PF02214;PF02218;PF02377;PF02825;PF02931;PF03165;PF03226;PF04055;PF06920;PF07525;PF07645;PF07653;PF07679;PF09279;PF09324;PF10409;PF12763;PF12783;PF12796;PF12924;PF13716;PF13855;PF13857;PF13920;PF14324;PF14429
Group	GO:0006928	cellular component movement	1	11.68	4.71e-22	1.86e-19	70|248|296|3527	PF00019;PF00024;PF00041;PF00045;PF00052;PF00053;PF00054;PF00055;PF00057;PF00096;PF00102;PF00130;PF00169;PF00200;PF00226;PF00241;PF00341;PF00388;PF00397;PF00400;PF00413;PF00435;PF00594;PF00611;PF00612;PF00618;PF00640;PF00684;PF00688;PF00757;PF00778;PF00786;PF00989;PF01030;PF01064;PF01217;PF01403;PF01437;PF01462;PF01833;PF01843;PF02148;PF02177;PF02181;PF02185;PF02210;PF02214;PF03133;PF03607;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07719;PF07728;PF08393;PF08447;PF09279;PF10409;PF12348;PF12473;PF12774;PF12775;PF12780;PF12924;PF13855;PF14429
Group	GO:0048519	negative regulation of biological process	1	10.53	1.40e-21	3.68e-19	111|248|681|3527	PF00019;PF00024;PF00041;PF00049;PF00057;PF00076;PF00090;PF00093;PF00096;PF00098;PF00102;PF00106;PF00122;PF00125;PF00130;PF00134;PF00169;PF00179;PF00200;PF00226;PF00240;PF00241;PF00249;PF00254;PF00341;PF00350;PF00388;PF00389;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00594;PF00611;PF00622;PF00625;PF00640;PF00643;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00789;PF00969;PF01030;PF01064;PF01335;PF01391;PF01400;PF01403;PF01417;PF01448;PF01462;PF01477;PF01585;PF01699;PF01753;PF01833;PF01909;PF02037;PF02145;PF02148;PF02177;PF02181;PF02201;PF02210;PF02214;PF02709;PF02826;PF02931;PF03165;PF03226;PF04055;PF05033;PF05773;PF06297;PF07525;PF07645;PF07653;PF07679;PF07719;PF08210;PF08246;PF09279;PF10277;PF10409;PF10421;PF12348;PF12697;PF12763;PF12796;PF12906;PF12924;PF12947;PF13415;PF13638;PF13716;PF13733;PF13854;PF13855;PF13857;PF13920;PF14324
Group	GO:0032879	regulation of localization	1	10.95	4.07e-20	8.04e-18	70|248|318|3527	PF00019;PF00027;PF00040;PF00041;PF00045;PF00049;PF00055;PF00076;PF00090;PF00093;PF00098;PF00102;PF00122;PF00130;PF00169;PF00200;PF00254;PF00341;PF00388;PF00397;PF00400;PF00413;PF00435;PF00452;PF00514;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00625;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00969;PF01030;PF01064;PF01217;PF01391;PF01403;PF01437;PF01833;PF01843;PF02145;PF02185;PF02204;PF02210;PF02214;PF02931;PF04055;PF04144;PF04810;PF07645;PF07653;PF07679;PF08246;PF09279;PF10409;PF12697;PF12796;PF13091;PF13426;PF13716;PF13855;PF13903;PF13920
Group	GO:0048583	regulation of response to stimulus	1	10.29	1.21e-19	1.91e-17	90|248|503|3527	PF00019;PF00027;PF00040;PF00041;PF00049;PF00057;PF00090;PF00093;PF00096;PF00102;PF00122;PF00130;PF00169;PF00179;PF00200;PF00240;PF00249;PF00341;PF00388;PF00397;PF00400;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00625;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF01030;PF01064;PF01217;PF01369;PF01391;PF01403;PF01417;PF01421;PF01437;PF01448;PF01462;PF01476;PF01585;PF01753;PF01833;PF01843;PF02037;PF02145;PF02148;PF02177;PF02204;PF02210;PF02214;PF02218;PF02377;PF02825;PF02931;PF03165;PF03226;PF04055;PF06920;PF07525;PF07534;PF07645;PF07653;PF07679;PF08246;PF09279;PF10409;PF12763;PF12796;PF12924;PF13716;PF13855;PF13857;PF13920;PF14324;PF14429
Group	GO:0040011	locomotion	1	10.67	1.59e-19	2.02e-17	72|248|342|3527	PF00019;PF00024;PF00041;PF00045;PF00052;PF00053;PF00054;PF00055;PF00057;PF00090;PF00096;PF00098;PF00102;PF00130;PF00169;PF00200;PF00226;PF00241;PF00341;PF00397;PF00413;PF00435;PF00514;PF00594;PF00611;PF00612;PF00618;PF00625;PF00640;PF00651;PF00684;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01391;PF01400;PF01403;PF01437;PF01462;PF01833;PF02145;PF02148;PF02177;PF02185;PF02210;PF02214;PF02931;PF03165;PF03607;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07728;PF08393;PF08447;PF10409;PF12348;PF12774;PF12775;PF12780;PF12924;PF13426;PF13855;PF14429
Group	GO:0048518	positive regulation of biological process	1	9.94	1.79e-19	2.02e-17	106|248|667|3527	PF00019;PF00024;PF00025;PF00027;PF00040;PF00041;PF00049;PF00053;PF00054;PF00055;PF00057;PF00076;PF00090;PF00093;PF00096;PF00098;PF00102;PF00122;PF00125;PF00130;PF00133;PF00134;PF00169;PF00179;PF00200;PF00240;PF00241;PF00249;PF00341;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00594;PF00611;PF00612;PF00618;PF00625;PF00640;PF00643;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF00989;PF01030;PF01064;PF01335;PF01391;PF01403;PF01417;PF01437;PF01448;PF01462;PF01476;PF01585;PF01699;PF01833;PF02037;PF02177;PF02181;PF02185;PF02204;PF02210;PF02218;PF02825;PF02845;PF02931;PF03165;PF04055;PF04144;PF05790;PF06367;PF06371;PF07525;PF07534;PF07645;PF07653;PF07679;PF07719;PF08210;PF08246;PF08447;PF09279;PF09816;PF10409;PF11717;PF12171;PF12697;PF12756;PF12763;PF12796;PF12924;PF13091;PF13716;PF13855;PF13920;PF14324
Group	GO:0051674	localization of cell	1	10.93	6.05e-19	5.97e-17	57|248|229|3527	PF00019;PF00024;PF00041;PF00045;PF00052;PF00053;PF00054;PF00055;PF00057;PF00096;PF00102;PF00130;PF00200;PF00226;PF00241;PF00341;PF00397;PF00413;PF00435;PF00514;PF00594;PF00611;PF00612;PF00618;PF00640;PF00684;PF00688;PF00757;PF00778;PF01030;PF01064;PF01403;PF01437;PF01462;PF01833;PF02148;PF02185;PF02210;PF02214;PF03607;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07728;PF08393;PF08447;PF10409;PF12348;PF12774;PF12775;PF12780;PF13855;PF14429
Group	GO:0007399	nervous system development	1	10.23	1.11e-18	9.71e-17	77|248|397|3527	PF00019;PF00024;PF00025;PF00041;PF00049;PF00052;PF00053;PF00054;PF00055;PF00057;PF00090;PF00096;PF00102;PF00122;PF00130;PF00169;PF00200;PF00249;PF00254;PF00341;PF00397;PF00400;PF00415;PF00435;PF00452;PF00514;PF00610;PF00611;PF00612;PF00618;PF00625;PF00640;PF00651;PF00688;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01369;PF01391;PF01400;PF01403;PF01421;PF01437;PF01462;PF01833;PF02023;PF02145;PF02148;PF02177;PF02181;PF02210;PF02377;PF02931;PF03165;PF03607;PF06367;PF06371;PF07525;PF07645;PF07653;PF07679;PF08516;PF10409;PF12348;PF12796;PF12924;PF13385;PF13716;PF13855;PF13857;PF13903;PF14324
Group	GO:0030030	cell projection organization	1	10.26	2.36e-17	1.86e-15	57|248|246|3527	PF00019;PF00024;PF00025;PF00041;PF00052;PF00053;PF00054;PF00055;PF00090;PF00096;PF00102;PF00130;PF00169;PF00341;PF00397;PF00400;PF00415;PF00435;PF00514;PF00581;PF00610;PF00611;PF00612;PF00618;PF00625;PF00640;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01391;PF01400;PF01403;PF01437;PF01462;PF01833;PF02148;PF02177;PF02210;PF02377;PF03133;PF03165;PF03607;PF07645;PF07653;PF07679;PF07719;PF12348;PF12796;PF12924;PF13716;PF13855;PF13857
Group	GO:0051641	cellular localization	1	9.54	2.87e-17	2.06e-15	85|248|494|3527	PF00019;PF00025;PF00027;PF00041;PF00053;PF00054;PF00076;PF00122;PF00130;PF00153;PF00169;PF00179;PF00226;PF00240;PF00341;PF00350;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00610;PF00611;PF00612;PF00618;PF00622;PF00625;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00786;PF00989;PF01217;PF01369;PF01391;PF01403;PF01417;PF01465;PF01843;PF02064;PF02145;PF02177;PF02181;PF02210;PF02828;PF02931;PF03645;PF03810;PF04144;PF04695;PF04810;PF07645;PF07653;PF07679;PF07707;PF07719;PF07728;PF08389;PF08393;PF08447;PF09279;PF09324;PF12171;PF12348;PF12473;PF12756;PF12763;PF12774;PF12775;PF12780;PF12783;PF12796;PF12924;PF13246;PF13385;PF13513;PF13855;PF13920
Group	GO:0051239	regulation of multicellular organismal process	1	9.59	3.74e-17	2.46e-15	80|248|448|3527	PF00019;PF00024;PF00025;PF00027;PF00041;PF00049;PF00054;PF00076;PF00090;PF00093;PF00096;PF00102;PF00122;PF00125;PF00130;PF00169;PF00200;PF00240;PF00249;PF00254;PF00341;PF00400;PF00435;PF00452;PF00514;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00688;PF00689;PF00690;PF00702;PF00778;PF00780;PF00786;PF00969;PF01064;PF01391;PF01403;PF01417;PF01437;PF01462;PF01699;PF01753;PF01833;PF01843;PF02023;PF02037;PF02177;PF02181;PF02210;PF02214;PF02377;PF02931;PF03165;PF03226;PF04055;PF04144;PF06367;PF06371;PF07525;PF07645;PF07653;PF07679;PF08246;PF10409;PF12763;PF12796;PF12924;PF12947;PF13426;PF13716;PF13855;PF13857
Group	GO:0009790	embryo development	1	9.92	5.57e-17	3.15e-15	63|248|299|3527	PF00019;PF00025;PF00041;PF00052;PF00053;PF00054;PF00057;PF00076;PF00093;PF00096;PF00102;PF00122;PF00125;PF00130;PF00133;PF00134;PF00169;PF00249;PF00341;PF00388;PF00400;PF00435;PF00452;PF00514;PF00583;PF00610;PF00612;PF00622;PF00625;PF00640;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00786;PF00989;PF01030;PF01064;PF01391;PF01403;PF01417;PF01448;PF01843;PF02145;PF02185;PF02210;PF02377;PF02828;PF03165;PF05033;PF06297;PF07525;PF07645;PF07653;PF07679;PF08447;PF09279;PF12796;PF13091;PF13857
Group	GO:0051128	regulation of cellular component organization	1	9.82	5.59e-17	3.15e-15	67|248|333|3527	PF00019;PF00024;PF00025;PF00041;PF00049;PF00096;PF00130;PF00134;PF00169;PF00179;PF00200;PF00226;PF00241;PF00249;PF00254;PF00341;PF00397;PF00400;PF00435;PF00452;PF00514;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00625;PF00640;PF00643;PF00651;PF00688;PF00757;PF00780;PF00786;PF01030;PF01064;PF01391;PF01403;PF01437;PF01462;PF01833;PF01843;PF02037;PF02145;PF02148;PF02181;PF02185;PF02210;PF02931;PF03165;PF06367;PF06371;PF07645;PF07653;PF07679;PF07707;PF07719;PF08210;PF10409;PF12348;PF12796;PF12895;PF12906;PF13091;PF13855;PF13920
Group	GO:0010646	regulation of cell communication	1	9.73	9.20e-17	4.84e-15	67|248|336|3527	PF00019;PF00027;PF00040;PF00041;PF00049;PF00057;PF00093;PF00096;PF00102;PF00122;PF00130;PF00169;PF00179;PF00240;PF00249;PF00341;PF00400;PF00435;PF00452;PF00514;PF00581;PF00594;PF00618;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF01030;PF01064;PF01391;PF01403;PF01417;PF01437;PF01448;PF01585;PF01699;PF01833;PF02037;PF02145;PF02210;PF02214;PF02218;PF02825;PF02931;PF03165;PF03226;PF04055;PF07525;PF07645;PF07653;PF07679;PF10409;PF12763;PF12796;PF13716;PF13855;PF13857;PF13920;PF14324
Group	GO:0007154	cell communication	1	9.03	1.20e-16	5.93e-15	103|248|691|3527	PF00019;PF00025;PF00027;PF00041;PF00049;PF00057;PF00076;PF00082;PF00090;PF00096;PF00098;PF00102;PF00106;PF00122;PF00130;PF00134;PF00169;PF00179;PF00200;PF00226;PF00240;PF00249;PF00341;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00625;PF00640;PF00643;PF00651;PF00683;PF00684;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00899;PF00969;PF00989;PF01030;PF01064;PF01179;PF01217;PF01370;PF01391;PF01403;PF01417;PF01421;PF01437;PF01462;PF01465;PF01833;PF01843;PF02023;PF02140;PF02145;PF02177;PF02185;PF02210;PF02214;PF02377;PF02759;PF02825;PF02828;PF02931;PF03165;PF05773;PF05790;PF07525;PF07645;PF07653;PF07679;PF07707;PF07719;PF08246;PF08447;PF08516;PF09279;PF10277;PF10409;PF12473;PF12763;PF12796;PF12874;PF12924;PF13426;PF13716;PF13855;PF13857
Group	GO:0065008	regulation of biological quality	1	9.10	1.35e-16	6.27e-15	97|248|628|3527	PF00019;PF00024;PF00025;PF00027;PF00041;PF00049;PF00057;PF00076;PF00082;PF00093;PF00096;PF00102;PF00106;PF00122;PF00130;PF00153;PF00169;PF00200;PF00240;PF00241;PF00249;PF00254;PF00341;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00583;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00625;PF00640;PF00643;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00786;PF01064;PF01217;PF01336;PF01391;PF01403;PF01417;PF01421;PF01437;PF01462;PF01477;PF01496;PF01553;PF01699;PF01843;PF02023;PF02037;PF02145;PF02148;PF02177;PF02181;PF02210;PF02214;PF02218;PF02225;PF02828;PF02931;PF03165;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07707;PF08246;PF08516;PF09279;PF10409;PF12171;PF12348;PF12756;PF12763;PF12796;PF12924;PF13246;PF13716;PF13855;PF13857;PF13903;PF14429
Group	GO:0032990	cell part morphogenesis	1	10.08	1.93e-16	8.47e-15	51|248|210|3527	PF00024;PF00025;PF00041;PF00052;PF00053;PF00054;PF00055;PF00090;PF00096;PF00102;PF00130;PF00169;PF00397;PF00400;PF00415;PF00435;PF00514;PF00581;PF00611;PF00625;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01391;PF01400;PF01403;PF01437;PF01462;PF01833;PF02148;PF02177;PF02210;PF02377;PF03133;PF03165;PF03607;PF07645;PF07653;PF07679;PF07719;PF12348;PF12796;PF12924;PF13716;PF13855;PF13857
Group	GO:0023052	signaling	1	8.92	3.92e-16	1.55e-14	98|248|648|3527	PF00019;PF00025;PF00027;PF00041;PF00049;PF00057;PF00076;PF00090;PF00096;PF00098;PF00102;PF00106;PF00122;PF00130;PF00134;PF00169;PF00179;PF00200;PF00226;PF00240;PF00249;PF00341;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00610;PF00611;PF00612;PF00618;PF00622;PF00625;PF00640;PF00643;PF00651;PF00683;PF00684;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF00989;PF01030;PF01064;PF01217;PF01370;PF01391;PF01403;PF01417;PF01421;PF01437;PF01462;PF01465;PF01833;PF01843;PF02023;PF02140;PF02145;PF02177;PF02185;PF02210;PF02214;PF02377;PF02759;PF02825;PF02828;PF02931;PF03165;PF05790;PF07525;PF07645;PF07653;PF07679;PF07707;PF07719;PF08246;PF08447;PF08516;PF09279;PF10277;PF10409;PF12473;PF12763;PF12796;PF12874;PF12924;PF13426;PF13716;PF13855;PF13857
Group	GO:0043412	macromolecule modification	1	8.69	2.74e-15	9.82e-14	92|248|602|3527	PF00019;PF00025;PF00027;PF00041;PF00049;PF00054;PF00076;PF00102;PF00130;PF00134;PF00169;PF00179;PF00200;PF00240;PF00249;PF00254;PF00341;PF00383;PF00397;PF00400;PF00415;PF00514;PF00581;PF00583;PF00594;PF00611;PF00622;PF00640;PF00643;PF00651;PF00688;PF00757;PF00780;PF00786;PF00899;PF00989;PF01030;PF01064;PF01448;PF01462;PF01585;PF01753;PF02037;PF02148;PF02177;PF02185;PF02201;PF02210;PF02214;PF02225;PF02709;PF02825;PF02845;PF03062;PF03133;PF03165;PF03256;PF03607;PF04055;PF04762;PF04810;PF05033;PF05773;PF06325;PF07645;PF07653;PF07679;PF07707;PF07719;PF08210;PF10277;PF10409;PF11717;PF12697;PF12796;PF12895;PF12906;PF12924;PF13091;PF13242;PF13344;PF13415;PF13426;PF13646;PF13733;PF13831;PF13832;PF13855;PF13857;PF13920;PF13964;PF14324
Group	GO:0065009	regulation of molecular function	1	9.00	3.55e-15	1.22e-13	71|248|396|3527	PF00019;PF00025;PF00027;PF00041;PF00049;PF00057;PF00076;PF00090;PF00102;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00254;PF00341;PF00388;PF00397;PF00400;PF00415;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00625;PF00640;PF00643;PF00688;PF00757;PF00778;PF00780;PF00786;PF00899;PF01335;PF01391;PF01403;PF01437;PF01585;PF01909;PF02145;PF02148;PF02177;PF02204;PF02210;PF02377;PF02931;PF03165;PF04055;PF06920;PF07258;PF07525;PF07645;PF07653;PF07679;PF08246;PF09279;PF09324;PF10421;PF12796;PF12924;PF13716;PF13855;PF13903;PF13920;PF14429
Group	GO:0000902	cell morphogenesis	1	9.33	4.08e-15	1.29e-13	56|248|265|3527	PF00019;PF00024;PF00025;PF00041;PF00052;PF00053;PF00054;PF00055;PF00090;PF00096;PF00102;PF00130;PF00169;PF00249;PF00397;PF00400;PF00415;PF00435;PF00514;PF00581;PF00611;PF00625;PF00640;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01391;PF01400;PF01403;PF01437;PF01462;PF01833;PF01843;PF02148;PF02177;PF02210;PF02377;PF03133;PF03165;PF03607;PF06920;PF07645;PF07653;PF07679;PF07719;PF12348;PF12796;PF12924;PF13716;PF13855;PF13857
Group	GO:0019538	protein metabolic process	1	8.24	8.46e-15	2.57e-13	115|248|869|3527	PF00019;PF00025;PF00027;PF00040;PF00041;PF00045;PF00049;PF00054;PF00057;PF00076;PF00082;PF00090;PF00102;PF00122;PF00130;PF00133;PF00134;PF00169;PF00179;PF00200;PF00226;PF00240;PF00249;PF00254;PF00341;PF00397;PF00400;PF00413;PF00415;PF00452;PF00514;PF00581;PF00583;PF00594;PF00611;PF00612;PF00622;PF00640;PF00643;PF00651;PF00684;PF00687;PF00688;PF00702;PF00757;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01336;PF01391;PF01400;PF01421;PF01448;PF01462;PF01546;PF01753;PF02037;PF02148;PF02177;PF02185;PF02201;PF02210;PF02214;PF02225;PF02709;PF02825;PF02845;PF03062;PF03133;PF03147;PF03165;PF03256;PF03607;PF04055;PF04137;PF04810;PF05033;PF05773;PF06325;PF07645;PF07653;PF07679;PF07687;PF07707;PF07719;PF08246;PF08516;PF08662;PF09409;PF10277;PF10409;PF11717;PF12697;PF12796;PF12895;PF12906;PF12924;PF13242;PF13344;PF13415;PF13426;PF13589;PF13646;PF13733;PF13831;PF13832;PF13855;PF13857;PF13920;PF13964;PF14324
Group	GO:0009605	response to external stimulus	1	9.00	9.39e-15	2.74e-13	63|248|330|3527	PF00019;PF00027;PF00041;PF00052;PF00053;PF00054;PF00055;PF00076;PF00082;PF00090;PF00096;PF00098;PF00102;PF00122;PF00200;PF00341;PF00397;PF00400;PF00435;PF00594;PF00612;PF00618;PF00622;PF00625;PF00640;PF00651;PF00688;PF00689;PF00690;PF00702;PF00778;PF00780;PF00786;PF00899;PF00969;PF01064;PF01179;PF01391;PF01400;PF01403;PF01437;PF01462;PF01833;PF02145;PF02148;PF02177;PF02210;PF02931;PF03165;PF05773;PF06920;PF07645;PF07679;PF08246;PF10409;PF12348;PF12796;PF12924;PF13091;PF13426;PF13855;PF13857;PF14429
Group	GO:0050793	regulation of developmental process	1	8.78	1.23e-14	3.46e-13	71|248|405|3527	PF00019;PF00024;PF00025;PF00041;PF00049;PF00057;PF00076;PF00090;PF00093;PF00096;PF00098;PF00102;PF00125;PF00130;PF00134;PF00169;PF00179;PF00200;PF00241;PF00249;PF00254;PF00341;PF00400;PF00435;PF00452;PF00514;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00688;PF00778;PF00780;PF00786;PF01064;PF01391;PF01403;PF01417;PF01437;PF01462;PF01753;PF01833;PF01843;PF02037;PF02177;PF02181;PF02185;PF02210;PF02377;PF02931;PF03165;PF03226;PF06367;PF06371;PF07525;PF07645;PF07679;PF08246;PF10409;PF12763;PF12796;PF12906;PF12924;PF12947;PF13716;PF13855
Group	GO:0042221	response to chemical stimulus	1	7.94	3.24e-13	8.25e-12	89|248|615|3527	PF00019;PF00027;PF00040;PF00041;PF00045;PF00049;PF00052;PF00053;PF00054;PF00055;PF00057;PF00076;PF00090;PF00093;PF00096;PF00098;PF00102;PF00122;PF00130;PF00134;PF00153;PF00169;PF00179;PF00200;PF00226;PF00240;PF00249;PF00341;PF00388;PF00397;PF00400;PF00413;PF00435;PF00452;PF00514;PF00583;PF00594;PF00612;PF00622;PF00625;PF00640;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF00989;PF01030;PF01064;PF01179;PF01370;PF01391;PF01400;PF01403;PF01437;PF01462;PF01833;PF01909;PF02145;PF02148;PF02177;PF02210;PF02218;PF02931;PF03165;PF06920;PF07525;PF07645;PF07653;PF07679;PF07719;PF08246;PF08416;PF08447;PF09279;PF10409;PF10421;PF12348;PF12796;PF12924;PF13426;PF13716;PF13855;PF14429
Group	GO:0000003	reproduction	1	8.21	3.65e-13	9.00e-12	69|248|412|3527	PF00019;PF00041;PF00045;PF00049;PF00053;PF00055;PF00076;PF00096;PF00098;PF00106;PF00122;PF00125;PF00130;PF00134;PF00169;PF00179;PF00188;PF00200;PF00226;PF00240;PF00249;PF00350;PF00388;PF00400;PF00413;PF00435;PF00452;PF00514;PF00612;PF00618;PF00622;PF00651;PF00684;PF00688;PF00702;PF00757;PF00780;PF00786;PF00989;PF01030;PF01064;PF01335;PF01421;PF01462;PF01465;PF01553;PF01753;PF02037;PF02177;PF02181;PF02931;PF03062;PF03165;PF05033;PF06325;PF07525;PF07653;PF07679;PF08516;PF09279;PF09335;PF12478;PF12796;PF12924;PF13091;PF13589;PF13855;PF13857;PF13920
Group	GO:0051234	establishment of localization	1	7.41	3.27e-12	7.38e-11	102|248|785|3527	PF00019;PF00025;PF00027;PF00040;PF00041;PF00049;PF00053;PF00057;PF00076;PF00102;PF00106;PF00122;PF00130;PF00153;PF00169;PF00179;PF00200;PF00226;PF00241;PF00249;PF00254;PF00341;PF00350;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00610;PF00611;PF00612;PF00618;PF00622;PF00625;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00989;PF01064;PF01217;PF01369;PF01391;PF01417;PF01448;PF01465;PF01477;PF01496;PF01553;PF01699;PF01833;PF01843;PF02064;PF02145;PF02177;PF02210;PF02214;PF02225;PF02828;PF02931;PF03645;PF03810;PF04144;PF04695;PF04810;PF06472;PF07258;PF07645;PF07653;PF07679;PF07707;PF07719;PF07728;PF08246;PF08389;PF08393;PF08447;PF09279;PF09324;PF10277;PF12473;PF12763;PF12774;PF12775;PF12780;PF12783;PF12796;PF12924;PF12947;PF13246;PF13385;PF13415;PF13418;PF13426;PF13513;PF13855
Group	GO:0051716	cellular response to stimulus	1	7.08	1.86e-11	4.07e-10	106|248|853|3527	PF00019;PF00025;PF00027;PF00040;PF00041;PF00049;PF00057;PF00076;PF00082;PF00090;PF00093;PF00096;PF00098;PF00102;PF00106;PF00122;PF00125;PF00130;PF00134;PF00169;PF00179;PF00200;PF00226;PF00240;PF00249;PF00341;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00583;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00625;PF00640;PF00643;PF00651;PF00683;PF00684;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00899;PF00969;PF00989;PF01030;PF01064;PF01179;PF01336;PF01370;PF01391;PF01403;PF01417;PF01437;PF01462;PF01833;PF01843;PF01909;PF02037;PF02140;PF02145;PF02177;PF02185;PF02377;PF02759;PF02825;PF02931;PF03165;PF04005;PF05773;PF05790;PF07525;PF07645;PF07653;PF07679;PF07707;PF07719;PF08246;PF08447;PF09279;PF10277;PF10409;PF10421;PF11717;PF12763;PF12796;PF12874;PF12924;PF13426;PF13589;PF13716;PF13855;PF13857;PF14324
Group	GO:0031323	regulation of cellular metabolic process	1	7.04	2.19e-11	4.66e-10	107|248|867|3527	PF00019;PF00027;PF00041;PF00049;PF00054;PF00057;PF00076;PF00096;PF00098;PF00102;PF00125;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00249;PF00254;PF00341;PF00389;PF00397;PF00400;PF00415;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00625;PF00640;PF00643;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01336;PF01352;PF01391;PF01403;PF01437;PF01448;PF01477;PF01585;PF01753;PF01833;PF02023;PF02037;PF02145;PF02148;PF02177;PF02201;PF02204;PF02210;PF02218;PF02377;PF02826;PF02845;PF02931;PF03165;PF04055;PF04762;PF05033;PF05773;PF06920;PF07258;PF07500;PF07525;PF07528;PF07645;PF07653;PF07679;PF07719;PF08210;PF08447;PF08662;PF08711;PF09816;PF11717;PF12171;PF12697;PF12756;PF12763;PF12796;PF12895;PF12924;PF13415;PF13716;PF13831;PF13832;PF13854;PF13855;PF13857;PF13920;PF14324;PF14429
Group	GO:0060255	regulation of macromolecule metabolic process	1	7.03	2.37e-11	4.91e-10	107|248|868|3527	PF00019;PF00024;PF00027;PF00041;PF00049;PF00054;PF00057;PF00076;PF00096;PF00098;PF00102;PF00125;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00249;PF00341;PF00389;PF00397;PF00400;PF00415;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00640;PF00643;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01335;PF01336;PF01352;PF01391;PF01400;PF01403;PF01437;PF01448;PF01477;PF01585;PF01753;PF01833;PF02023;PF02037;PF02145;PF02148;PF02177;PF02201;PF02204;PF02210;PF02218;PF02377;PF02826;PF02845;PF02931;PF03165;PF04055;PF04762;PF05033;PF05773;PF06325;PF07258;PF07500;PF07525;PF07528;PF07645;PF07653;PF07679;PF07719;PF08210;PF08246;PF08447;PF08662;PF08711;PF09816;PF10409;PF11717;PF12171;PF12756;PF12763;PF12796;PF12895;PF12924;PF13091;PF13415;PF13638;PF13716;PF13831;PF13832;PF13854;PF13855;PF13857;PF13920;PF14324
Group	GO:0080090	regulation of primary metabolic process	1	6.97	3.47e-11	6.69e-10	106|248|861|3527	PF00019;PF00024;PF00027;PF00041;PF00049;PF00054;PF00057;PF00076;PF00096;PF00098;PF00102;PF00125;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00249;PF00341;PF00389;PF00397;PF00400;PF00415;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00640;PF00643;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01335;PF01336;PF01352;PF01391;PF01403;PF01437;PF01448;PF01585;PF01753;PF01833;PF02023;PF02037;PF02145;PF02148;PF02177;PF02201;PF02204;PF02210;PF02218;PF02377;PF02826;PF02845;PF02931;PF03165;PF04055;PF04762;PF05033;PF05773;PF06920;PF07258;PF07500;PF07525;PF07528;PF07645;PF07653;PF07679;PF07719;PF08210;PF08447;PF08662;PF08711;PF09816;PF11717;PF12171;PF12697;PF12756;PF12763;PF12796;PF12895;PF12924;PF13415;PF13716;PF13831;PF13832;PF13854;PF13855;PF13857;PF13920;PF14324;PF14429
Group	GO:0007163	establishment or maintenance of cell polarity	1	8.36	8.56e-11	1.41e-09	26|248|88|3527	PF00041;PF00052;PF00053;PF00054;PF00057;PF00130;PF00169;PF00400;PF00435;PF00610;PF00612;PF00625;PF00651;PF00778;PF00786;PF01369;PF01843;PF02181;PF02210;PF02828;PF06367;PF06371;PF07653;PF07679;PF12348;PF13855
Group	GO:0033036	macromolecule localization	1	6.16	2.69e-08	2.91e-07	53|248|354|3527	PF00019;PF00025;PF00041;PF00052;PF00053;PF00054;PF00057;PF00076;PF00122;PF00130;PF00169;PF00226;PF00240;PF00241;PF00350;PF00397;PF00400;PF00435;PF00514;PF00581;PF00611;PF00625;PF00683;PF00688;PF00778;PF01064;PF01217;PF01391;PF01465;PF01477;PF02064;PF02145;PF02210;PF02828;PF03810;PF04144;PF04695;PF04810;PF06472;PF07645;PF07653;PF07679;PF08389;PF10277;PF10409;PF12348;PF12763;PF12796;PF13246;PF13415;PF13418;PF13513;PF13855
Group	GO:0051171	regulation of nitrogen compound metabolic process	1	5.70	7.02e-08	7.01e-07	79|248|647|3527	PF00019;PF00027;PF00041;PF00049;PF00076;PF00096;PF00098;PF00125;PF00130;PF00134;PF00169;PF00179;PF00226;PF00249;PF00341;PF00389;PF00397;PF00400;PF00435;PF00514;PF00610;PF00611;PF00612;PF00618;PF00643;PF00651;PF00688;PF00757;PF00780;PF00899;PF00989;PF01030;PF01336;PF01352;PF01391;PF01403;PF01437;PF01448;PF01585;PF01753;PF01833;PF02023;PF02037;PF02145;PF02177;PF02201;PF02204;PF02826;PF03165;PF04762;PF05033;PF06920;PF07258;PF07500;PF07528;PF07645;PF07653;PF07679;PF07719;PF08210;PF08447;PF08711;PF09816;PF11717;PF12171;PF12756;PF12796;PF12895;PF12924;PF13415;PF13716;PF13831;PF13832;PF13854;PF13855;PF13857;PF13920;PF14324;PF14429
Group	GO:0002376	immune system process	1	5.96	7.39e-08	7.29e-07	50|248|334|3527	PF00019;PF00041;PF00057;PF00090;PF00096;PF00102;PF00130;PF00153;PF00169;PF00179;PF00200;PF00240;PF00249;PF00254;PF00341;PF00350;PF00388;PF00452;PF00514;PF00594;PF00612;PF00625;PF00643;PF00651;PF00688;PF00780;PF00969;PF01335;PF01391;PF01476;PF01909;PF02037;PF02218;PF02931;PF04055;PF04810;PF05790;PF07534;PF07645;PF07653;PF07679;PF08246;PF09279;PF10409;PF10421;PF12697;PF12796;PF13855;PF13857;PF14324
Group	GO:0006950	response to stress	1	5.61	9.15e-08	8.78e-07	84|248|709|3527	PF00019;PF00024;PF00027;PF00040;PF00041;PF00045;PF00049;PF00057;PF00076;PF00082;PF00093;PF00098;PF00102;PF00122;PF00125;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00249;PF00341;PF00350;PF00400;PF00413;PF00435;PF00452;PF00581;PF00594;PF00618;PF00622;PF00625;PF00640;PF00643;PF00651;PF00684;PF00688;PF00689;PF00690;PF00702;PF00757;PF00780;PF00786;PF00899;PF00969;PF00989;PF01030;PF01179;PF01336;PF01391;PF01476;PF01477;PF01833;PF01843;PF01909;PF02037;PF02145;PF02177;PF02210;PF02931;PF04005;PF04055;PF05773;PF05790;PF06920;PF07534;PF07645;PF07653;PF07679;PF08246;PF08447;PF10277;PF10409;PF10421;PF11717;PF12697;PF12924;PF12947;PF13589;PF13716;PF13855;PF14324;PF14429
Group	GO:0044260	cellular macromolecule metabolic process	1	4.00	4.88e-05	2.35e-04	130|248|1425|3527	PF00019;PF00025;PF00027;PF00041;PF00049;PF00054;PF00057;PF00076;PF00082;PF00096;PF00098;PF00102;PF00122;PF00125;PF00130;PF00133;PF00134;PF00169;PF00179;PF00200;PF00226;PF00240;PF00249;PF00254;PF00341;PF00383;PF00397;PF00400;PF00415;PF00452;PF00514;PF00581;PF00583;PF00594;PF00611;PF00622;PF00640;PF00643;PF00651;PF00684;PF00687;PF00688;PF00702;PF00757;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01336;PF01370;PF01448;PF01462;PF01480;PF01585;PF01753;PF01909;PF02023;PF02037;PF02148;PF02177;PF02185;PF02201;PF02210;PF02214;PF02225;PF02269;PF02709;PF02825;PF02845;PF02878;PF03062;PF03133;PF03147;PF03165;PF03256;PF03607;PF03828;PF04055;PF04137;PF04762;PF04810;PF05033;PF05485;PF05773;PF06325;PF07034;PF07500;PF07528;PF07645;PF07653;PF07679;PF07707;PF07719;PF08075;PF08210;PF08447;PF08662;PF08711;PF09409;PF10277;PF10409;PF11717;PF12171;PF12697;PF12796;PF12874;PF12895;PF12906;PF12924;PF13091;PF13242;PF13344;PF13415;PF13426;PF13589;PF13638;PF13646;PF13656;PF13691;PF13733;PF13831;PF13832;PF13855;PF13857;PF13920;PF13964;PF14324
Group	GO:0009889	regulation of biosynthetic process	1	3.67	2.92e-04	1.07e-03	67|248|646|3527	PF00019;PF00049;PF00076;PF00096;PF00098;PF00125;PF00130;PF00134;PF00169;PF00179;PF00249;PF00341;PF00389;PF00397;PF00400;PF00435;PF00514;PF00643;PF00651;PF00688;PF00757;PF00899;PF00989;PF01030;PF01064;PF01336;PF01352;PF01391;PF01448;PF01585;PF01753;PF01833;PF02023;PF02037;PF02177;PF02201;PF02826;PF03165;PF04762;PF05033;PF05773;PF07258;PF07500;PF07528;PF07645;PF07679;PF07719;PF08210;PF08447;PF08662;PF08711;PF09816;PF11717;PF12171;PF12756;PF12796;PF12895;PF12924;PF13415;PF13716;PF13831;PF13832;PF13854;PF13855;PF13857;PF13920;PF14324
Group	GO:0009056	catabolic process	1	3.25	1.24e-03	3.61e-03	56|248|543|3527	PF00019;PF00025;PF00049;PF00082;PF00098;PF00122;PF00134;PF00153;PF00179;PF00205;PF00226;PF00240;PF00350;PF00383;PF00397;PF00400;PF00452;PF00456;PF00583;PF00612;PF00622;PF00643;PF00688;PF00689;PF00690;PF00702;PF00789;PF00899;PF00970;PF01370;PF01391;PF01477;PF01546;PF01571;PF01597;PF01909;PF02148;PF02214;PF02825;PF02845;PF03256;PF03828;PF06472;PF07707;PF07728;PF08210;PF08246;PF08442;PF09409;PF10409;PF12697;PF12895;PF13589;PF13638;PF13646;PF13920
Group	GO:0001932	regulation of protein phosphorylation	2	10.21	3.57e-16	1.48e-14	45|248|169|3527	PF00019;PF00027;PF00041;PF00049;PF00057;PF00102;PF00134;PF00169;PF00226;PF00240;PF00341;PF00400;PF00415;PF00452;PF00581;PF00594;PF00610;PF00640;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01391;PF01403;PF01437;PF01585;PF02145;PF02177;PF02210;PF02218;PF02377;PF02931;PF04055;PF07525;PF07645;PF07653;PF07679;PF12796;PF12924;PF13716;PF13855;PF13920
Group	GO:0016477	cell migration	2	10.04	5.38e-16	2.02e-14	47|248|185|3527	PF00019;PF00041;PF00045;PF00052;PF00053;PF00054;PF00055;PF00057;PF00096;PF00102;PF00130;PF00200;PF00341;PF00397;PF00413;PF00435;PF00594;PF00611;PF00612;PF00618;PF00640;PF00688;PF00757;PF00778;PF01030;PF01064;PF01403;PF01437;PF01462;PF01833;PF02148;PF02185;PF02210;PF02214;PF03607;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF08447;PF10409;PF12348;PF13855;PF14429
Group	GO:0060541	respiratory system development	2	10.59	4.03e-15	1.29e-13	30|248|82|3527	PF00019;PF00041;PF00045;PF00049;PF00057;PF00102;PF00130;PF00240;PF00341;PF00413;PF00435;PF00625;PF00640;PF00688;PF01064;PF01391;PF02037;PF02181;PF02828;PF03165;PF06367;PF06371;PF07645;PF07653;PF07679;PF08246;PF08447;PF10409;PF13855;PF13903
Group	GO:0030198	extracellular matrix organization	2	10.23	1.03e-13	2.79e-12	25|248|63|3527	PF00019;PF00041;PF00045;PF00052;PF00053;PF00054;PF00055;PF00057;PF00090;PF00093;PF00397;PF00413;PF00640;PF00688;PF01391;PF01421;PF02177;PF02210;PF02709;PF04810;PF07679;PF12924;PF13716;PF13733;PF13855
Group	GO:0051130	positive regulation of cellular component organization	2	9.61	1.31e-13	3.44e-12	32|248|104|3527	PF00019;PF00025;PF00041;PF00241;PF00249;PF00341;PF00397;PF00400;PF00452;PF00514;PF00594;PF00611;PF00625;PF00688;PF00786;PF01064;PF01391;PF01403;PF01437;PF01462;PF02181;PF02185;PF02210;PF03165;PF06367;PF06371;PF07653;PF07679;PF07719;PF12796;PF13091;PF13855
Group	GO:0007444	imaginal disc development	2	9.54	7.21e-13	1.72e-11	27|248|79|3527	PF00041;PF00045;PF00076;PF00096;PF00130;PF00397;PF00413;PF00435;PF00612;PF00625;PF00651;PF01064;PF01369;PF01400;PF01448;PF01476;PF01833;PF02037;PF03165;PF07534;PF07645;PF07653;PF07679;PF12796;PF13855;PF13920;PF14324
Group	GO:0035556	intracellular signal transduction	2	8.61	1.32e-12	3.05e-11	42|248|184|3527	PF00025;PF00027;PF00041;PF00049;PF00098;PF00122;PF00130;PF00134;PF00169;PF00240;PF00397;PF00400;PF00435;PF00452;PF00581;PF00610;PF00611;PF00612;PF00618;PF00625;PF00640;PF00643;PF00651;PF00689;PF00690;PF00702;PF00780;PF00786;PF01843;PF02145;PF02185;PF02759;PF07525;PF07645;PF07653;PF07679;PF08246;PF10277;PF10409;PF12763;PF13716;PF13855
Group	GO:0018193	peptidyl-amino acid modification	2	8.16	2.56e-11	5.17e-10	36|248|153|3527	PF00041;PF00054;PF00130;PF00169;PF00240;PF00249;PF00254;PF00341;PF00397;PF00400;PF00581;PF00583;PF00594;PF00611;PF00757;PF00899;PF01030;PF01462;PF01753;PF02210;PF02709;PF03062;PF03133;PF04810;PF05033;PF06325;PF07645;PF07679;PF07719;PF11717;PF12796;PF13646;PF13733;PF13831;PF13832;PF13855
Group	GO:2000145	regulation of cell motility	2	8.44	3.14e-11	6.20e-10	29|248|104|3527	PF00019;PF00041;PF00045;PF00055;PF00090;PF00093;PF00102;PF00130;PF00200;PF00341;PF00388;PF00413;PF00625;PF00688;PF00757;PF01030;PF01391;PF01403;PF01437;PF01833;PF02185;PF07645;PF07653;PF07679;PF08246;PF09279;PF10409;PF13716;PF13855
Group	GO:0051241	negative regulation of multicellular organismal process	2	8.82	3.66e-11	6.87e-10	23|248|67|3527	PF00019;PF00041;PF00102;PF00122;PF00169;PF00200;PF00240;PF00341;PF00594;PF00651;PF00688;PF00689;PF00690;PF00702;PF00969;PF01391;PF01699;PF02931;PF07525;PF07645;PF10409;PF12796;PF13857
Group	GO:0007552	metamorphosis	2	8.64	5.33e-11	9.77e-10	24|248|74|3527	PF00045;PF00076;PF00096;PF00102;PF00130;PF00397;PF00413;PF00435;PF00612;PF00651;PF01064;PF01369;PF01400;PF01448;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF10409;PF12796;PF13855;PF13920
Group	GO:0051640	organelle localization	2	8.32	6.35e-11	1.11e-09	28|248|100|3527	PF00130;PF00169;PF00350;PF00388;PF00400;PF00435;PF00612;PF00640;PF00651;PF00780;PF00786;PF01403;PF01843;PF02181;PF03645;PF04810;PF07707;PF07719;PF07728;PF08393;PF09279;PF12171;PF12473;PF12756;PF12774;PF12775;PF12780;PF13920
Group	GO:0043549	regulation of kinase activity	2	8.07	6.30e-11	1.11e-09	33|248|135|3527	PF00019;PF00027;PF00041;PF00049;PF00102;PF00134;PF00169;PF00240;PF00341;PF00400;PF00415;PF00581;PF00640;PF00688;PF00778;PF00780;PF00786;PF01391;PF01585;PF02145;PF02177;PF02210;PF02931;PF04055;PF07525;PF07645;PF07653;PF07679;PF12796;PF12924;PF13716;PF13855;PF13920
Group	GO:0002165	instar larval or pupal development	2	8.49	7.02e-11	1.20e-09	25|248|81|3527	PF00045;PF00076;PF00096;PF00102;PF00130;PF00397;PF00413;PF00435;PF00514;PF00612;PF00651;PF01064;PF01369;PF01400;PF01448;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF10409;PF12796;PF13855;PF13920
Group	GO:0051056	regulation of small GTPase mediated signal transduction	2	8.63	7.30e-11	1.23e-09	23|248|69|3527	PF00041;PF00130;PF00169;PF00610;PF00611;PF00612;PF00618;PF00651;PF00780;PF01369;PF01403;PF01437;PF01833;PF02145;PF02204;PF02214;PF06920;PF07653;PF07679;PF12796;PF13716;PF13855;PF14429
Group	GO:0009968	negative regulation of signal transduction	2	7.74	1.49e-10	2.40e-09	36|248|162|3527	PF00019;PF00041;PF00049;PF00057;PF00093;PF00096;PF00102;PF00130;PF00169;PF00249;PF00400;PF00514;PF00581;PF00640;PF00651;PF00683;PF00688;PF00778;PF01391;PF01448;PF01585;PF01833;PF02037;PF02145;PF02210;PF02214;PF03165;PF03226;PF07525;PF07645;PF07679;PF10409;PF12763;PF12796;PF13855;PF14324
Group	GO:0032270	positive regulation of cellular protein metabolic process	2	7.81	1.80e-10	2.85e-09	33|248|140|3527	PF00019;PF00041;PF00049;PF00057;PF00076;PF00134;PF00179;PF00240;PF00249;PF00341;PF00400;PF00594;PF00640;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01391;PF02204;PF02210;PF02218;PF02845;PF02931;PF07645;PF07653;PF07679;PF07719;PF12763;PF13855;PF14324
Group	GO:0007411	axon guidance	2	8.13	3.36e-10	5.20e-09	24|248|80|3527	PF00041;PF00052;PF00102;PF00397;PF00435;PF00625;PF00651;PF00778;PF00780;PF01064;PF01391;PF01400;PF01403;PF01437;PF01462;PF01833;PF02148;PF02177;PF02210;PF03165;PF07645;PF07679;PF12924;PF13855
Group	GO:0010740	positive regulation of intracellular protein kinase cascade	2	8.18	3.63e-10	5.52e-09	23|248|74|3527	PF00019;PF00041;PF00049;PF00122;PF00130;PF00179;PF00240;PF00341;PF00594;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF01030;PF01391;PF02218;PF07653;PF07679;PF12763;PF13920
Group	GO:0009886	post-embryonic morphogenesis	2	7.94	5.15e-10	7.67e-09	25|248|88|3527	PF00045;PF00076;PF00096;PF00102;PF00130;PF00397;PF00413;PF00435;PF00452;PF00612;PF00651;PF01064;PF01369;PF01400;PF01448;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF10409;PF12796;PF13855;PF13920
Group	GO:0035239	tube morphogenesis	2	7.68	7.38e-10	1.06e-08	28|248|110|3527	PF00019;PF00045;PF00049;PF00090;PF00096;PF00130;PF00341;PF00400;PF00413;PF00435;PF00514;PF00625;PF00651;PF00688;PF00786;PF00989;PF01391;PF01403;PF01437;PF02145;PF03165;PF05033;PF07653;PF07679;PF07707;PF08246;PF08447;PF13855
Group	GO:0006508	proteolysis	2	7.32	7.39e-10	1.06e-08	37|248|179|3527	PF00040;PF00045;PF00057;PF00076;PF00082;PF00090;PF00134;PF00179;PF00200;PF00226;PF00240;PF00397;PF00400;PF00413;PF00452;PF00594;PF00612;PF00622;PF00643;PF00789;PF01400;PF01421;PF01546;PF02148;PF02214;PF02225;PF02825;PF02845;PF03256;PF07687;PF07707;PF08246;PF08516;PF12895;PF13589;PF13646;PF13920
Group	GO:0044057	regulation of system process	2	7.58	8.84e-10	1.25e-08	29|248|118|3527	PF00019;PF00027;PF00041;PF00102;PF00122;PF00130;PF00169;PF00254;PF00341;PF00435;PF00514;PF00618;PF00688;PF00689;PF00690;PF00702;PF01391;PF01699;PF01833;PF02210;PF02214;PF02931;PF03226;PF07653;PF07679;PF12796;PF13426;PF13855;PF13857
Group	GO:0042060	wound healing	2	7.74	1.35e-09	1.86e-08	24|248|85|3527	PF00024;PF00027;PF00041;PF00093;PF00122;PF00130;PF00169;PF00341;PF00435;PF00594;PF00618;PF00622;PF00643;PF00689;PF00690;PF00702;PF00757;PF00786;PF01030;PF06920;PF07653;PF07679;PF13716;PF14429
Group	GO:0034330	cell junction organization	2	7.86	1.86e-09	2.54e-08	21|248|67|3527	PF00019;PF00041;PF00052;PF00053;PF00055;PF00102;PF00130;PF00169;PF00435;PF00514;PF00625;PF00640;PF00688;PF00786;PF01391;PF02210;PF02828;PF07645;PF07653;PF07679;PF13903
Group	GO:0001763	morphogenesis of a branching structure	2	7.77	2.53e-09	3.38e-08	21|248|68|3527	PF00019;PF00045;PF00049;PF00090;PF00130;PF00341;PF00413;PF00435;PF00625;PF00688;PF00786;PF01064;PF01403;PF01437;PF01833;PF07645;PF07653;PF07679;PF08246;PF08447;PF13855
Group	GO:0051301	cell division	2	7.45	3.04e-09	3.99e-08	25|248|95|3527	PF00019;PF00025;PF00076;PF00096;PF00130;PF00134;PF00169;PF00241;PF00350;PF00435;PF00452;PF00514;PF00612;PF00640;PF00651;PF00688;PF00780;PF00786;PF01064;PF02181;PF03165;PF06367;PF06371;PF07707;PF13964
Group	GO:0006461	protein complex assembly	2	6.98	3.36e-09	4.35e-08	36|248|180|3527	PF00019;PF00025;PF00041;PF00093;PF00125;PF00130;PF00134;PF00169;PF00179;PF00350;PF00400;PF00452;PF00611;PF00622;PF00625;PF00643;PF00688;PF00757;PF00778;PF00969;PF01030;PF01064;PF01391;PF02148;PF02181;PF02214;PF03165;PF04695;PF06309;PF06367;PF06371;PF07645;PF07679;PF07719;PF12763;PF12947
Group	GO:0010975	regulation of neuron projection development	2	7.65	4.91e-09	6.25e-08	20|248|64|3527	PF00025;PF00041;PF00096;PF00200;PF00254;PF00435;PF00611;PF00780;PF01403;PF01437;PF01462;PF01833;PF02181;PF02931;PF06367;PF06371;PF07679;PF10409;PF12796;PF13855
Group	GO:0048569	post-embryonic organ development	2	7.31	6.12e-09	7.57e-08	24|248|91|3527	PF00045;PF00076;PF00096;PF00130;PF00249;PF00397;PF00413;PF00435;PF00452;PF00612;PF00651;PF01064;PF01369;PF01400;PF01448;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF12796;PF13855;PF13920
Group	GO:0007610	behavior	2	6.96	6.22e-09	7.57e-08	32|248|151|3527	PF00027;PF00057;PF00076;PF00096;PF00122;PF00130;PF00200;PF00397;PF00435;PF00612;PF00625;PF00640;PF00651;PF00689;PF00690;PF00702;PF00970;PF00989;PF01369;PF01421;PF01465;PF01699;PF02177;PF02210;PF02214;PF02931;PF07653;PF08516;PF12796;PF12924;PF13716;PF13855
Group	GO:0048737	imaginal disc-derived appendage development	2	7.63	6.90e-09	8.25e-08	19|248|59|3527	PF00076;PF00096;PF00130;PF00397;PF00435;PF00612;PF00651;PF01064;PF01369;PF01400;PF01448;PF01476;PF01833;PF03165;PF07534;PF07645;PF12796;PF13855;PF13920
Group	GO:0010562	positive regulation of phosphorus metabolic process	2	7.19	7.70e-09	9.06e-08	25|248|99|3527	PF00019;PF00041;PF00049;PF00054;PF00057;PF00134;PF00240;PF00341;PF00594;PF00640;PF00688;PF00778;PF00780;PF00786;PF01064;PF01391;PF01403;PF02210;PF02218;PF02931;PF07645;PF07653;PF07679;PF12763;PF13855
Group	GO:0060560	developmental growth involved in morphogenesis	2	7.53	9.47e-09	1.10e-07	19|248|60|3527	PF00019;PF00041;PF00057;PF00130;PF00625;PF00688;PF00786;PF01064;PF01391;PF01843;PF02177;PF02828;PF03607;PF07653;PF07679;PF12796;PF12924;PF13855;PF13857
Group	GO:0031329	regulation of cellular catabolic process	2	7.01	1.04e-08	1.19e-07	27|248|115|3527	PF00027;PF00041;PF00076;PF00130;PF00169;PF00226;PF00240;PF00400;PF00514;PF00610;PF00611;PF00612;PF00618;PF00778;PF00780;PF00789;PF01403;PF01437;PF02145;PF02148;PF02204;PF06920;PF07653;PF12697;PF13716;PF13855;PF14429
Group	GO:0032446	protein modification by small protein conjugation	2	6.96	1.27e-08	1.43e-07	27|248|116|3527	PF00179;PF00240;PF00397;PF00415;PF00514;PF00622;PF00643;PF00651;PF00899;PF02037;PF02148;PF02201;PF02214;PF02225;PF02825;PF02845;PF03256;PF05773;PF07707;PF07719;PF12796;PF12895;PF12906;PF13857;PF13920;PF13964;PF14324
Group	GO:0030097	hemopoiesis	2	6.98	1.39e-08	1.55e-07	26|248|109|3527	PF00019;PF00041;PF00096;PF00102;PF00130;PF00153;PF00169;PF00249;PF00341;PF00452;PF00514;PF00612;PF00643;PF00651;PF00688;PF00780;PF02037;PF02218;PF04055;PF05790;PF07645;PF07679;PF12796;PF13855;PF13857;PF14324
Group	GO:0010769	regulation of cell morphogenesis involved in differentiation	2	7.24	2.34e-08	2.57e-07	19|248|63|3527	PF00019;PF00041;PF00200;PF00435;PF00514;PF00688;PF00780;PF01403;PF01437;PF01462;PF01833;PF02181;PF02210;PF02931;PF03165;PF06367;PF06371;PF07679;PF13855
Group	GO:0006468	protein phosphorylation	2	6.65	2.96e-08	3.15e-07	29|248|136|3527	PF00019;PF00027;PF00041;PF00049;PF00130;PF00134;PF00169;PF00200;PF00240;PF00341;PF00611;PF00640;PF00688;PF00757;PF00780;PF00786;PF00989;PF01030;PF01064;PF02177;PF02185;PF03165;PF03607;PF07645;PF07653;PF07679;PF12924;PF13426;PF13855
Group	GO:0051347	positive regulation of transferase activity	2	7.02	3.02e-08	3.18e-07	21|248|77|3527	PF00019;PF00041;PF00049;PF00057;PF00134;PF00169;PF00240;PF00341;PF00400;PF00640;PF00688;PF00778;PF00780;PF00786;PF01391;PF02210;PF02931;PF07645;PF07653;PF07679;PF13855
Group	GO:0001558	regulation of cell growth	2	7.04	3.60e-08	3.73e-07	20|248|71|3527	PF00019;PF00041;PF00134;PF00179;PF00200;PF00226;PF00435;PF00640;PF00643;PF00688;PF00757;PF01030;PF01403;PF01437;PF01462;PF02210;PF07679;PF10409;PF12796;PF13855
Group	GO:0007268	synaptic transmission	2	6.52	4.12e-08	4.22e-07	30|248|146|3527	PF00025;PF00041;PF00122;PF00130;PF00169;PF00435;PF00622;PF00640;PF00651;PF00690;PF00786;PF01064;PF01217;PF01417;PF01462;PF02177;PF02210;PF02214;PF02828;PF02931;PF03165;PF07653;PF07679;PF07707;PF12473;PF12763;PF12796;PF12924;PF13426;PF13855
Group	GO:0035107	appendage morphogenesis	2	6.70	6.05e-08	6.12e-07	23|248|94|3527	PF00057;PF00076;PF00096;PF00130;PF00397;PF00435;PF00452;PF00612;PF00651;PF01064;PF01369;PF01400;PF01448;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07719;PF12796;PF13855;PF13920
Group	GO:0007600	sensory perception	2	6.58	9.24e-08	8.78e-07	23|248|96|3527	PF00024;PF00027;PF00053;PF00055;PF00106;PF00122;PF00350;PF00415;PF00612;PF00625;PF00689;PF00690;PF00702;PF01391;PF01477;PF02931;PF03607;PF07653;PF07679;PF07719;PF12796;PF13385;PF13857
Group	GO:0046903	secretion	2	6.49	9.21e-08	8.78e-07	25|248|111|3527	PF00019;PF00025;PF00027;PF00041;PF00122;PF00130;PF00169;PF00341;PF00610;PF00612;PF00618;PF00640;PF00683;PF00688;PF00702;PF01217;PF01417;PF01553;PF02210;PF02828;PF02931;PF04144;PF07645;PF07679;PF12763
Group	GO:0021700	developmental maturation	2	6.65	1.55e-07	1.44e-06	19|248|70|3527	PF00019;PF00041;PF00076;PF00130;PF00134;PF00169;PF00435;PF00622;PF00651;PF00688;PF01833;PF01843;PF02177;PF07525;PF07679;PF12796;PF12924;PF13091;PF13855
Group	GO:0060341	regulation of cellular localization	2	6.19	1.55e-07	1.44e-06	29|248|146|3527	PF00019;PF00027;PF00076;PF00098;PF00169;PF00514;PF00594;PF00610;PF00612;PF00618;PF00622;PF00688;PF00757;PF00778;PF00969;PF01030;PF01064;PF01391;PF01833;PF01843;PF02214;PF02931;PF04055;PF04144;PF04810;PF12796;PF13091;PF13716;PF13855
Group	GO:0032535	regulation of cellular component size	2	6.57	2.39e-07	2.19e-06	18|248|65|3527	PF00041;PF00130;PF00169;PF00200;PF00241;PF00400;PF00435;PF00786;PF01403;PF01437;PF01462;PF02145;PF02181;PF02210;PF07653;PF07679;PF10409;PF13855
Group	GO:0051235	maintenance of location	2	7.00	2.75e-07	2.50e-06	13|248|35|3527	PF00122;PF00241;PF00400;PF00435;PF00683;PF00689;PF00690;PF00702;PF07645;PF12171;PF12348;PF12756;PF12796
Group	GO:0007018	microtubule-based movement	2	6.51	3.64e-07	3.27e-06	17|248|60|3527	PF00169;PF00400;PF00435;PF00612;PF00989;PF01217;PF02177;PF03133;PF07719;PF07728;PF08393;PF08447;PF12473;PF12774;PF12775;PF12780;PF12924
Group	GO:0030900	forebrain development	2	6.29	3.94e-07	3.49e-06	20|248|81|3527	PF00019;PF00041;PF00057;PF00096;PF00249;PF00640;PF00688;PF00757;PF01030;PF01064;PF01462;PF02177;PF02210;PF03165;PF03607;PF07645;PF07679;PF12924;PF13716;PF13855
Group	GO:0003002	regionalization	2	5.96	4.36e-07	3.82e-06	27|248|136|3527	PF00019;PF00041;PF00057;PF00076;PF00093;PF00096;PF00102;PF00130;PF00249;PF00400;PF00514;PF00612;PF00622;PF00651;PF00688;PF00778;PF01064;PF01448;PF02377;PF03165;PF05033;PF06297;PF07525;PF07679;PF12796;PF13091;PF13857
Group	GO:0008360	regulation of cell shape	2	6.42	4.74e-07	4.11e-06	17|248|61|3527	PF00024;PF00130;PF00169;PF00341;PF00611;PF00612;PF00618;PF00780;PF00786;PF01403;PF01437;PF01843;PF02181;PF06367;PF06371;PF07679;PF10409
Group	GO:0044087	regulation of cellular component biogenesis	2	6.05	5.32e-07	4.56e-06	23|248|105|3527	PF00025;PF00041;PF00130;PF00241;PF00249;PF00341;PF00400;PF00452;PF00611;PF00612;PF00622;PF00625;PF00786;PF01064;PF01462;PF02181;PF02210;PF03165;PF06367;PF06371;PF07653;PF10409;PF12796
Group	GO:0016358	dendrite development	2	6.50	6.03e-07	4.99e-06	15|248|49|3527	PF00024;PF00041;PF00053;PF00096;PF00435;PF00640;PF00780;PF00786;PF01064;PF02177;PF03607;PF07653;PF07679;PF12796;PF12924
Group	GO:0051240	positive regulation of multicellular organismal process	2	6.05	6.07e-07	4.99e-06	22|248|98|3527	PF00019;PF00027;PF00054;PF00122;PF00130;PF00169;PF00341;PF00594;PF00688;PF00689;PF00690;PF00702;PF01064;PF01391;PF01699;PF02210;PF04055;PF07645;PF07679;PF12796;PF13716;PF13855
Group	GO:0045597	positive regulation of cell differentiation	2	6.05	6.07e-07	4.99e-06	22|248|98|3527	PF00019;PF00041;PF00090;PF00093;PF00096;PF00098;PF00130;PF00341;PF00400;PF00514;PF00640;PF00688;PF01064;PF01391;PF01403;PF01437;PF03165;PF07525;PF07645;PF07679;PF12796;PF13855
Group	GO:0007292	female gamete generation	2	6.19	6.33e-07	5.15e-06	19|248|76|3527	PF00076;PF00106;PF00130;PF00134;PF00200;PF00350;PF00435;PF00514;PF00612;PF00618;PF00622;PF00651;PF01064;PF03165;PF07525;PF07653;PF07679;PF13091;PF13920
Group	GO:0001654	eye development	2	5.95	6.48e-07	5.21e-06	24|248|114|3527	PF00019;PF00041;PF00053;PF00096;PF00102;PF00130;PF00400;PF00415;PF00452;PF00514;PF00612;PF00618;PF00651;PF00688;PF01064;PF01843;PF02037;PF02210;PF03607;PF07679;PF10409;PF13716;PF13920;PF14324
Group	GO:0030155	regulation of cell adhesion	2	6.09	7.43e-07	5.92e-06	20|248|84|3527	PF00019;PF00041;PF00093;PF00102;PF00130;PF00169;PF00200;PF00341;PF00612;PF00651;PF00688;PF01064;PF01369;PF01391;PF01421;PF07645;PF07653;PF07679;PF10409;PF13716
Group	GO:0007346	regulation of mitotic cell cycle	2	5.94	8.80e-07	6.94e-06	22|248|100|3527	PF00019;PF00076;PF00096;PF00130;PF00134;PF00341;PF00397;PF00452;PF00625;PF00640;PF00688;PF01448;PF02037;PF02148;PF02177;PF03645;PF07653;PF07679;PF12796;PF12895;PF12924;PF14324
Group	GO:0060627	regulation of vesicle-mediated transport	2	6.26	9.37e-07	7.32e-06	16|248|57|3527	PF00169;PF00341;PF00397;PF00400;PF00594;PF00610;PF00611;PF00618;PF01391;PF01833;PF02145;PF02210;PF04144;PF07645;PF13091;PF13920
Group	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2	5.96	1.11e-06	8.45e-06	20|248|86|3527	PF00019;PF00041;PF00049;PF00130;PF00169;PF00341;PF00388;PF00618;PF00640;PF00688;PF00757;PF01030;PF02145;PF07525;PF07645;PF07653;PF07679;PF09279;PF10409;PF13855
Group	GO:1900542	regulation of purine nucleotide metabolic process	2	5.96	1.11e-06	8.45e-06	20|248|86|3527	PF00027;PF00041;PF00130;PF00169;PF00226;PF00514;PF00610;PF00611;PF00612;PF00618;PF00780;PF01403;PF01437;PF02145;PF02204;PF06920;PF07653;PF13716;PF13855;PF14429
Group	GO:0048610	cellular process involved in reproduction	2	5.49	1.35e-06	1.02e-05	33|248|197|3527	PF00019;PF00041;PF00076;PF00098;PF00130;PF00134;PF00179;PF00200;PF00240;PF00350;PF00388;PF00435;PF00452;PF00612;PF00622;PF00651;PF00688;PF00786;PF01064;PF01753;PF02931;PF03165;PF05033;PF06325;PF07525;PF07653;PF07679;PF09279;PF12796;PF13091;PF13589;PF13857;PF13920
Group	GO:0051345	positive regulation of hydrolase activity	2	5.82	1.45e-06	1.08e-05	21|248|95|3527	PF00019;PF00025;PF00041;PF00130;PF00169;PF00226;PF00452;PF00514;PF00610;PF00611;PF00612;PF00643;PF00688;PF02145;PF02204;PF06920;PF07679;PF08246;PF13716;PF13920;PF14429
Group	GO:0001822	kidney development	2	5.95	1.58e-06	1.16e-05	18|248|73|3527	PF00019;PF00025;PF00041;PF00096;PF00102;PF00240;PF00341;PF00400;PF00452;PF00612;PF00651;PF00688;PF01391;PF07679;PF07707;PF08246;PF13716;PF13857
Group	GO:0048732	gland development	2	5.85	1.82e-06	1.33e-05	19|248|81|3527	PF00041;PF00049;PF00096;PF00102;PF00122;PF00200;PF00341;PF00514;PF00702;PF00757;PF00989;PF01030;PF01391;PF01403;PF01553;PF02210;PF07679;PF10409;PF13716
Group	GO:0008544	epidermis development	2	5.88	1.95e-06	1.41e-05	18|248|74|3527	PF00019;PF00093;PF00122;PF00249;PF00400;PF00514;PF00612;PF00622;PF00688;PF00689;PF00702;PF00757;PF01030;PF01391;PF01843;PF07679;PF12796;PF13855
Group	GO:0016049	cell growth	2	6.01	2.40e-06	1.72e-05	15|248|54|3527	PF00041;PF00130;PF00651;PF00786;PF01064;PF01843;PF02177;PF03607;PF07679;PF07707;PF12796;PF12924;PF13716;PF13855;PF13857
Group	GO:0072347	response to anesthetic	2	7.53	2.83e-06	2.00e-05	6|248|8|3527	PF00052;PF00053;PF00054;PF00057;PF02210;PF07679
Group	GO:0045199	maintenance of epithelial cell apical/basal polarity	2	7.53	2.83e-06	2.00e-05	6|248|8|3527	PF00052;PF00053;PF00054;PF00057;PF02210;PF07679
Group	GO:0048511	rhythmic process	2	5.92	3.10e-06	2.17e-05	15|248|55|3527	PF00019;PF00027;PF00041;PF00076;PF00098;PF00249;PF00452;PF00583;PF00688;PF00989;PF01421;PF02931;PF07679;PF08447;PF13716
Group	GO:0048638	regulation of developmental growth	2	5.78	3.15e-06	2.18e-05	17|248|69|3527	PF00019;PF00134;PF00179;PF00200;PF00435;PF00611;PF00612;PF00622;PF00688;PF01064;PF01403;PF01437;PF01462;PF02210;PF03165;PF07679;PF13855
Group	GO:0023061	signal release	2	5.83	3.21e-06	2.20e-05	16|248|62|3527	PF00019;PF00025;PF00027;PF00130;PF00169;PF00610;PF00618;PF00640;PF00683;PF00688;PF01217;PF01417;PF02210;PF02828;PF07645;PF12763
Group	GO:0043408	regulation of MAPK cascade	2	5.65	3.27e-06	2.23e-05	19|248|84|3527	PF00049;PF00130;PF00169;PF00341;PF00397;PF00514;PF00581;PF00625;PF00640;PF00757;PF00778;PF00780;PF00786;PF01030;PF01391;PF01843;PF07653;PF07679;PF13855
Group	GO:0006909	phagocytosis	2	5.94	3.65e-06	2.44e-05	14|248|49|3527	PF00041;PF00053;PF00057;PF00102;PF00106;PF00130;PF00200;PF00249;PF00400;PF01217;PF01391;PF01448;PF07645;PF07679
Group	GO:0016337	cell-cell adhesion	2	5.94	3.65e-06	2.44e-05	14|248|49|3527	PF00041;PF00054;PF00102;PF00122;PF00169;PF00514;PF00625;PF00688;PF00689;PF00690;PF00702;PF02210;PF07679;PF13855
Group	GO:0051216	cartilage development	2	5.99	4.09e-06	2.71e-05	13|248|43|3527	PF00019;PF00052;PF00053;PF00054;PF00057;PF00093;PF00688;PF01064;PF01391;PF02210;PF03165;PF07645;PF07679
Group	GO:0007283	spermatogenesis	2	5.60	4.42e-06	2.88e-05	18|248|78|3527	PF00041;PF00179;PF00200;PF00226;PF00240;PF00350;PF00452;PF00612;PF00651;PF00684;PF00780;PF01421;PF01753;PF02037;PF07679;PF08516;PF12796;PF13091
Group	GO:0043269	regulation of ion transport	2	5.53	4.76e-06	3.05e-05	19|248|86|3527	PF00122;PF00169;PF00254;PF00341;PF00397;PF00435;PF00452;PF00514;PF00594;PF00622;PF00625;PF00689;PF00690;PF00702;PF02210;PF07653;PF12796;PF13426;PF13903
Group	GO:0071310	cellular response to organic substance	2	5.09	4.74e-06	3.05e-05	36|248|237|3527	PF00019;PF00041;PF00049;PF00076;PF00093;PF00098;PF00102;PF00130;PF00169;PF00179;PF00226;PF00240;PF00249;PF00341;PF00400;PF00452;PF00514;PF00583;PF00622;PF00640;PF00688;PF00757;PF00969;PF01030;PF01064;PF01179;PF01391;PF01909;PF03165;PF07525;PF07653;PF07679;PF07719;PF10409;PF10421;PF13855
Group	GO:0050817	coagulation	2	5.67	5.05e-06	3.21e-05	16|248|64|3527	PF00024;PF00027;PF00041;PF00093;PF00122;PF00130;PF00169;PF00341;PF00594;PF00618;PF00689;PF00690;PF00702;PF06920;PF07679;PF14429
Group	GO:0034762	regulation of transmembrane transport	2	5.47	6.49e-06	4.10e-05	18|248|80|3527	PF00019;PF00254;PF00341;PF00397;PF00514;PF00622;PF00625;PF00688;PF00757;PF00778;PF01030;PF01391;PF02210;PF07653;PF12796;PF13716;PF13855;PF13903
Group	GO:0031532	actin cytoskeleton reorganization	2	6.47	7.45e-06	4.67e-05	8|248|17|3527	PF00122;PF00130;PF00612;PF00640;PF00689;PF00690;PF00702;PF00780
Group	GO:0030163	protein catabolic process	2	5.26	7.64e-06	4.75e-05	22|248|113|3527	PF00082;PF00134;PF00179;PF00226;PF00240;PF00397;PF00400;PF00452;PF00622;PF00643;PF00789;PF02148;PF02214;PF02825;PF02845;PF03256;PF07707;PF09409;PF12895;PF13589;PF13646;PF13920
Group	GO:0009798	axis specification	2	5.65	7.89e-06	4.87e-05	14|248|52|3527	PF00057;PF00076;PF00130;PF00400;PF00612;PF00622;PF00651;PF00778;PF01064;PF03165;PF05033;PF06297;PF07525;PF13091
Group	GO:0051248	negative regulation of protein metabolic process	2	5.20	8.30e-06	5.04e-05	23|248|122|3527	PF00019;PF00041;PF00076;PF00098;PF00102;PF00134;PF00226;PF00240;PF00400;PF00452;PF00581;PF00688;PF00789;PF01335;PF01391;PF01585;PF02145;PF02148;PF05773;PF07525;PF12796;PF13716;PF13920
Group	GO:0000278	mitotic cell cycle	2	5.15	8.77e-06	5.28e-05	24|248|131|3527	PF00019;PF00130;PF00134;PF00179;PF00400;PF00452;PF00581;PF00688;PF00780;PF01336;PF01833;PF02037;PF02148;PF02177;PF07679;PF07728;PF08393;PF12348;PF12774;PF12775;PF12780;PF12895;PF12924;PF14324
Group	GO:0050878	regulation of body fluid levels	2	5.35	9.41e-06	5.58e-05	18|248|82|3527	PF00024;PF00027;PF00041;PF00093;PF00102;PF00122;PF00130;PF00169;PF00341;PF00594;PF00618;PF00689;PF00690;PF00702;PF01553;PF06920;PF07679;PF14429
Group	GO:0050776	regulation of immune response	2	5.11	1.19e-05	7.02e-05	22|248|116|3527	PF00041;PF00057;PF00090;PF00102;PF00130;PF00169;PF00179;PF00240;PF00388;PF00611;PF00625;PF00651;PF00969;PF01391;PF01476;PF04055;PF07534;PF07645;PF07679;PF08246;PF09279;PF13855
Group	GO:0036075	replacement ossification	2	6.22	1.26e-05	7.31e-05	8|248|18|3527	PF00019;PF00052;PF00053;PF00054;PF00057;PF00688;PF02210;PF07679
Group	GO:0002684	positive regulation of immune system process	2	5.02	1.59e-05	9.07e-05	22|248|118|3527	PF00041;PF00057;PF00090;PF00096;PF00102;PF00130;PF00169;PF00179;PF00240;PF00388;PF00611;PF00625;PF00651;PF00969;PF01391;PF01476;PF04055;PF05790;PF07534;PF07645;PF09279;PF13855
Group	GO:0032844	regulation of homeostatic process	2	5.23	1.74e-05	9.90e-05	16|248|70|3527	PF00019;PF00041;PF00057;PF00102;PF00179;PF00249;PF00254;PF00388;PF00452;PF00622;PF00688;PF00969;PF03226;PF09279;PF12796;PF13716
Group	GO:0016569	covalent chromatin modification	2	4.97	1.82e-05	1.03e-04	22|248|119|3527	PF00076;PF00130;PF00134;PF00179;PF00249;PF00254;PF00397;PF00400;PF00583;PF00622;PF01448;PF01753;PF02148;PF05033;PF06325;PF07719;PF11717;PF12796;PF13415;PF13831;PF13832;PF13857
Group	GO:0042176	regulation of protein catabolic process	2	5.49	1.85e-05	1.04e-04	12|248|42|3527	PF00240;PF00397;PF00400;PF00514;PF00778;PF00789;PF01335;PF02037;PF02148;PF07525;PF13920;PF14324
Group	GO:0032101	regulation of response to external stimulus	2	5.07	1.88e-05	1.04e-04	19|248|94|3527	PF00019;PF00027;PF00041;PF00130;PF00200;PF00341;PF00594;PF00625;PF00688;PF01391;PF01403;PF01421;PF01437;PF01462;PF01833;PF02210;PF07653;PF07679;PF13855
Group	GO:0044092	negative regulation of molecular function	2	4.87	1.94e-05	1.07e-04	25|248|146|3527	PF00041;PF00076;PF00102;PF00134;PF00169;PF00254;PF00397;PF00400;PF00452;PF00581;PF00594;PF00625;PF00688;PF01391;PF01585;PF02145;PF02148;PF02210;PF07258;PF07525;PF07653;PF09324;PF12796;PF13716;PF13920
Group	GO:0045786	negative regulation of cell cycle	2	5.30	2.01e-05	1.10e-04	14|248|56|3527	PF00019;PF00106;PF00134;PF00350;PF00397;PF00625;PF00640;PF00688;PF01477;PF02148;PF07645;PF07653;PF07679;PF10409
Group	GO:0001738	morphogenesis of a polarized epithelium	2	5.66	2.11e-05	1.13e-04	10|248|30|3527	PF00053;PF00130;PF00514;PF00612;PF00625;PF00651;PF01843;PF02210;PF02828;PF06297
Group	GO:0001568	blood vessel development	2	4.99	2.10e-05	1.13e-04	20|248|103|3527	PF00019;PF00090;PF00093;PF00102;PF00106;PF00169;PF00341;PF00618;PF00640;PF00688;PF01064;PF01403;PF01437;PF01833;PF02037;PF02210;PF07645;PF07679;PF12796;PF13716
Group	GO:0030111	regulation of Wnt receptor signaling pathway	2	5.22	2.49e-05	1.29e-04	14|248|57|3527	PF00019;PF00041;PF00057;PF00102;PF00400;PF00514;PF00612;PF00688;PF00778;PF01391;PF02825;PF07679;PF12796;PF13857
Group	GO:0030031	cell projection assembly	2	5.22	2.49e-05	1.29e-04	14|248|57|3527	PF00041;PF00102;PF00169;PF00341;PF00400;PF00581;PF00610;PF00612;PF00778;PF01833;PF02377;PF03133;PF03607;PF07719
Group	GO:0072507	divalent inorganic cation homeostasis	2	5.09	2.55e-05	1.31e-04	16|248|72|3527	PF00041;PF00102;PF00122;PF00130;PF00254;PF00388;PF00452;PF00622;PF00689;PF00690;PF00702;PF01699;PF02177;PF02931;PF09279;PF12924
Group	GO:0009416	response to light stimulus	2	4.84	2.75e-05	1.41e-04	22|248|122|3527	PF00057;PF00076;PF00098;PF00122;PF00134;PF00226;PF00249;PF00400;PF00452;PF00689;PF00690;PF00702;PF00989;PF02037;PF02177;PF02931;PF08447;PF12924;PF13426;PF13716;PF13855;PF13857
Group	GO:0010564	regulation of cell cycle process	2	4.75	3.58e-05	1.81e-04	22|248|124|3527	PF00019;PF00076;PF00130;PF00134;PF00240;PF00341;PF00397;PF00400;PF00452;PF00514;PF00640;PF00688;PF01336;PF01448;PF02037;PF02148;PF02185;PF04005;PF07679;PF12796;PF12895;PF14324
Group	GO:0051494	negative regulation of cytoskeleton organization	2	5.31	3.64e-05	1.83e-04	11|248|38|3527	PF00041;PF00241;PF00254;PF00400;PF00435;PF00514;PF00622;PF00643;PF07653;PF12348;PF12796
Group	GO:0009725	response to hormone stimulus	2	4.66	4.06e-05	2.00e-04	24|248|143|3527	PF00019;PF00041;PF00045;PF00049;PF00102;PF00130;PF00169;PF00249;PF00388;PF00413;PF00452;PF00514;PF00640;PF00688;PF00757;PF01030;PF01064;PF01391;PF02218;PF07525;PF07653;PF09279;PF10409;PF13855
Group	GO:0007548	sex differentiation	2	4.90	4.36e-05	2.14e-04	16|248|75|3527	PF00019;PF00041;PF00076;PF00096;PF00098;PF00125;PF00134;PF00400;PF00452;PF00651;PF00688;PF00989;PF01064;PF01421;PF01462;PF07679
Group	GO:0008285	negative regulation of cell proliferation	2	4.75	4.69e-05	2.28e-04	19|248|100|3527	PF00019;PF00102;PF00350;PF00514;PF00625;PF00688;PF00786;PF00969;PF01391;PF01753;PF02145;PF02709;PF03165;PF06297;PF07679;PF07719;PF10409;PF13716;PF13733
Group	GO:0051050	positive regulation of transport	2	4.71	5.77e-05	2.73e-04	18|248|93|3527	PF00019;PF00040;PF00049;PF00076;PF00169;PF00341;PF00397;PF00400;PF00452;PF00594;PF00688;PF00969;PF01391;PF02210;PF04144;PF12796;PF13091;PF13855
Group	GO:0072511	divalent inorganic cation transport	2	4.83	6.03e-05	2.83e-04	15|248|69|3527	PF00041;PF00102;PF00122;PF00254;PF00388;PF00622;PF00625;PF00689;PF00690;PF00702;PF01699;PF01833;PF02931;PF09279;PF12796
Group	GO:0080135	regulation of cellular response to stress	2	4.68	7.05e-05	3.29e-04	17|248|86|3527	PF00040;PF00041;PF00049;PF00169;PF00179;PF00397;PF00452;PF00625;PF00640;PF00778;PF00780;PF00786;PF01753;PF01843;PF02037;PF07653;PF13855
Group	GO:0042981	regulation of apoptotic process	2	4.32	7.10e-05	3.30e-04	33|248|236|3527	PF00019;PF00024;PF00041;PF00049;PF00082;PF00090;PF00130;PF00169;PF00240;PF00341;PF00397;PF00452;PF00514;PF00594;PF00640;PF00643;PF00688;PF00757;PF01030;PF01064;PF01335;PF01391;PF01585;PF02037;PF07653;PF07679;PF08246;PF10277;PF10409;PF12763;PF13716;PF13855;PF13920
Group	GO:0045165	cell fate commitment	2	4.60	7.17e-05	3.31e-04	19|248|103|3527	PF00019;PF00076;PF00096;PF00130;PF00200;PF00249;PF00435;PF00625;PF00651;PF00688;PF00989;PF01064;PF01465;PF02828;PF03165;PF07645;PF07653;PF07679;PF10409
Group	GO:0042391	regulation of membrane potential	2	4.71	7.24e-05	3.32e-04	16|248|78|3527	PF00041;PF00169;PF00200;PF00452;PF00612;PF00625;PF01421;PF02023;PF02210;PF02214;PF02931;PF07653;PF07679;PF08516;PF12796;PF13716
Group	GO:0030001	metal ion transport	2	4.49	7.58e-05	3.44e-04	22|248|130|3527	PF00027;PF00041;PF00102;PF00122;PF00153;PF00254;PF00388;PF00622;PF00625;PF00651;PF00689;PF00690;PF00702;PF01699;PF01833;PF02214;PF02225;PF02931;PF07707;PF09279;PF12796;PF13426
Group	GO:0045765	regulation of angiogenesis	2	4.90	7.97e-05	3.51e-04	12|248|48|3527	PF00041;PF00090;PF00093;PF00102;PF00130;PF00169;PF00341;PF00643;PF07645;PF08246;PF12947;PF13716
Group	GO:0007015	actin filament organization	2	4.76	8.26e-05	3.62e-04	14|248|63|3527	PF00241;PF00400;PF00611;PF00612;PF00625;PF01064;PF01417;PF02181;PF02214;PF06367;PF06371;PF07653;PF10409;PF12796
Group	GO:0007422	peripheral nervous system development	2	5.01	9.41e-05	4.08e-04	10|248|35|3527	PF00019;PF00041;PF00169;PF00200;PF00757;PF01030;PF01421;PF07679;PF08516;PF13716
Group	GO:0007219	Notch signaling pathway	2	5.01	9.41e-05	4.08e-04	10|248|35|3527	PF00096;PF00200;PF00400;PF01370;PF01417;PF01833;PF01843;PF02825;PF07645;PF12796
Group	GO:0032880	regulation of protein localization	2	4.59	9.98e-05	4.30e-04	16|248|80|3527	PF00019;PF00514;PF00622;PF00688;PF00757;PF00778;PF00969;PF01030;PF01391;PF02204;PF02210;PF04055;PF04144;PF12796;PF13716;PF13855
Group	GO:0008038	neuron recognition	2	5.22	1.04e-04	4.44e-04	8|248|23|3527	PF00041;PF00435;PF00651;PF01400;PF01437;PF02177;PF07679;PF12924
Group	GO:0060348	bone development	2	4.79	1.27e-04	5.27e-04	11|248|43|3527	PF00019;PF00052;PF00053;PF00054;PF00057;PF00622;PF00688;PF01391;PF02210;PF07645;PF07679
Group	GO:0012501	programmed cell death	2	4.28	1.31e-04	5.34e-04	23|248|144|3527	PF00027;PF00090;PF00102;PF00130;PF00240;PF00452;PF00514;PF00651;PF00757;PF00786;PF00989;PF01030;PF01335;PF02177;PF07653;PF08246;PF08447;PF10409;PF12874;PF12924;PF13716;PF13855;PF13920
Group	GO:0006357	regulation of transcription from RNA polymerase II promoter	2	4.22	1.34e-04	5.45e-04	26|248|173|3527	PF00019;PF00049;PF00400;PF00435;PF00514;PF00651;PF00688;PF00989;PF01833;PF02037;PF02177;PF02201;PF03165;PF04762;PF07500;PF07645;PF07679;PF08447;PF08711;PF12796;PF12924;PF13415;PF13716;PF13854;PF13857;PF13920
Group	GO:0050890	cognition	2	4.62	1.35e-04	5.48e-04	13|248|58|3527	PF00057;PF00122;PF00397;PF00689;PF00690;PF00702;PF01699;PF02177;PF02210;PF02931;PF07653;PF12924;PF13716
Group	GO:0008283	cell proliferation	2	4.25	1.46e-04	5.85e-04	23|248|145|3527	PF00019;PF00027;PF00041;PF00076;PF00096;PF00102;PF00130;PF00134;PF00249;PF00254;PF00341;PF00452;PF00625;PF00640;PF00688;PF01064;PF02148;PF03165;PF05485;PF07653;PF07679;PF10409;PF12874
Group	GO:0072657	protein localization to membrane	2	4.78	1.57e-04	6.27e-04	10|248|37|3527	PF00053;PF00054;PF00169;PF00611;PF00625;PF01391;PF02210;PF07653;PF07679;PF12796
Group	GO:0030705	cytoskeleton-dependent intracellular transport	2	4.60	1.97e-04	7.63e-04	11|248|45|3527	PF00169;PF00400;PF00435;PF00612;PF00989;PF01217;PF02177;PF07719;PF08447;PF12473;PF12924
Group	GO:0051051	negative regulation of transport	2	4.47	1.95e-04	7.63e-04	13|248|60|3527	PF00019;PF00130;PF00397;PF00400;PF00611;PF00622;PF00688;PF01064;PF01391;PF01833;PF04055;PF12796;PF13716
Group	GO:0001701	in utero embryonic development	2	4.48	2.22e-04	8.46e-04	12|248|53|3527	PF00169;PF00249;PF00341;PF00640;PF00757;PF00989;PF01030;PF01064;PF01417;PF03165;PF07679;PF08447
Group	GO:0030003	cellular cation homeostasis	2	4.18	2.30e-04	8.71e-04	19|248|112|3527	PF00041;PF00102;PF00122;PF00130;PF00254;PF00388;PF00400;PF00452;PF00622;PF00689;PF00690;PF00702;PF01496;PF01699;PF02177;PF02225;PF02931;PF09279;PF12924
Group	GO:2000027	regulation of organ morphogenesis	2	4.40	2.33e-04	8.75e-04	13|248|61|3527	PF00019;PF00400;PF00452;PF00514;PF00610;PF00640;PF00688;PF00778;PF01064;PF02377;PF03165;PF07679;PF12796
Group	GO:0030855	epithelial cell differentiation	2	4.35	2.33e-04	8.75e-04	14|248|69|3527	PF00019;PF00024;PF00041;PF00049;PF00102;PF00130;PF00514;PF00612;PF00640;PF00688;PF01064;PF03165;PF07645;PF07679
Group	GO:0031110	regulation of microtubule polymerization or depolymerization	2	4.69	2.43e-04	9.06e-04	9|248|32|3527	PF00025;PF00041;PF00254;PF00435;PF00514;PF00622;PF00643;PF12348;PF12796
Group	GO:0045926	negative regulation of growth	2	4.51	2.44e-04	9.06e-04	11|248|46|3527	PF00019;PF00226;PF00611;PF00622;PF00640;PF00643;PF00688;PF01403;PF01462;PF02210;PF10409
Group	GO:0040017	positive regulation of locomotion	2	4.40	2.68e-04	9.93e-04	12|248|54|3527	PF00019;PF00053;PF00055;PF00090;PF00093;PF00130;PF00169;PF00200;PF00341;PF00688;PF07679;PF08246
Group	GO:0048705	skeletal system morphogenesis	2	4.42	2.99e-04	1.09e-03	11|248|47|3527	PF00019;PF00052;PF00053;PF00054;PF00057;PF00688;PF01391;PF02210;PF03165;PF07645;PF07679
Group	GO:0070482	response to oxygen levels	2	4.32	3.22e-04	1.15e-03	12|248|55|3527	PF00019;PF00045;PF00341;PF00413;PF00643;PF00688;PF00989;PF02037;PF02145;PF02931;PF08447;PF13716
Group	GO:0050678	regulation of epithelial cell proliferation	2	4.32	3.22e-04	1.15e-03	12|248|55|3527	PF00019;PF00041;PF00102;PF00130;PF00341;PF00514;PF00688;PF00757;PF01030;PF01064;PF03165;PF07679
Group	GO:0007369	gastrulation	2	4.25	3.84e-04	1.36e-03	12|248|56|3527	PF00019;PF00025;PF00076;PF00102;PF00130;PF00435;PF00583;PF00688;PF00778;PF01064;PF03165;PF06297
Group	GO:0001817	regulation of cytokine production	2	4.04	4.61e-04	1.63e-03	15|248|82|3527	PF00019;PF00076;PF00130;PF00240;PF00622;PF00651;PF00688;PF00969;PF01391;PF02023;PF02931;PF04055;PF04144;PF12796;PF13855
Group	GO:0006898	receptor-mediated endocytosis	2	4.48	4.82e-04	1.68e-03	8|248|28|3527	PF00040;PF00057;PF00169;PF00350;PF00397;PF00611;PF07645;PF12947
Group	GO:0055123	digestive system development	2	4.28	4.86e-04	1.69e-03	10|248|42|3527	PF00019;PF00041;PF00049;PF00096;PF00400;PF00688;PF00757;PF01030;PF03165;PF07679
Group	GO:0051052	regulation of DNA metabolic process	2	4.04	4.99e-04	1.70e-03	14|248|74|3527	PF00019;PF00134;PF00179;PF00249;PF00341;PF00651;PF00688;PF01336;PF01391;PF02037;PF07679;PF12171;PF12756;PF12895
Group	GO:0043069	negative regulation of programmed cell death	2	3.89	5.31e-04	1.78e-03	18|248|110|3527	PF00019;PF00041;PF00049;PF00130;PF00169;PF00341;PF00452;PF00594;PF00688;PF00757;PF01030;PF02037;PF07653;PF08246;PF10277;PF12763;PF13855;PF13920
Group	GO:0055065	metal ion homeostasis	2	3.94	5.41e-04	1.79e-03	16|248|92|3527	PF00041;PF00102;PF00122;PF00130;PF00254;PF00388;PF00452;PF00622;PF00689;PF00690;PF00702;PF02177;PF02225;PF02931;PF09279;PF12924
Group	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	2	4.19	5.95e-04	1.94e-03	10|248|43|3527	PF00019;PF00106;PF00341;PF00397;PF00683;PF00688;PF01064;PF03165;PF07645;PF12874
Group	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	2	4.19	5.95e-04	1.94e-03	10|248|43|3527	PF00019;PF00090;PF00093;PF00096;PF00683;PF00688;PF01064;PF03165;PF07645;PF12796
Group	GO:0050808	synapse organization	2	4.19	5.95e-04	1.94e-03	10|248|43|3527	PF00130;PF00625;PF00690;PF02177;PF02210;PF07653;PF07679;PF12796;PF12924;PF13857
Group	GO:0019216	regulation of lipid metabolic process	2	4.00	6.15e-04	2.00e-03	13|248|67|3527	PF00019;PF00041;PF00049;PF00098;PF00169;PF00341;PF00400;PF00688;PF01391;PF07653;PF07679;PF07719;PF12697
Group	GO:0007009	plasma membrane organization	2	4.24	6.35e-04	2.04e-03	9|248|36|3527	PF00054;PF00169;PF00435;PF00611;PF00622;PF00643;PF01391;PF02210;PF12796
Group	GO:0034621	cellular macromolecular complex subunit organization	2	3.67	6.96e-04	2.22e-03	24|248|171|3527	PF00019;PF00025;PF00041;PF00076;PF00125;PF00130;PF00134;PF00169;PF00179;PF00241;PF00400;PF00583;PF00611;PF00688;PF01064;PF01585;PF02181;PF03165;PF06325;PF06367;PF06371;PF07679;PF07719;PF12874
Group	GO:0008213	protein alkylation	2	4.10	7.23e-04	2.24e-03	10|248|44|3527	PF00076;PF00134;PF00400;PF00622;PF01753;PF05033;PF06325;PF07719;PF12796;PF13857
Group	GO:0006836	neurotransmitter transport	2	4.10	7.23e-04	2.24e-03	10|248|44|3527	PF00122;PF00130;PF00169;PF00640;PF00690;PF01217;PF01417;PF02210;PF02828;PF12763
Group	GO:0045321	leukocyte activation	2	3.73	8.59e-04	2.64e-03	17|248|105|3527	PF00041;PF00096;PF00102;PF00130;PF00249;PF00254;PF00452;PF00514;PF00625;PF00651;PF00780;PF02931;PF04055;PF05790;PF07653;PF07679;PF13855
Group	GO:0007519	skeletal muscle tissue development	2	3.89	8.74e-04	2.66e-03	12|248|61|3527	PF00041;PF00049;PF00200;PF00622;PF00625;PF01369;PF02177;PF06920;PF07679;PF12796;PF12924;PF13857
Group	GO:0042063	gliogenesis	2	3.94	8.95e-04	2.72e-03	11|248|53|3527	PF00049;PF00169;PF00200;PF00757;PF01030;PF01421;PF03165;PF07679;PF08516;PF13716;PF13903
Group	GO:0060249	anatomical structure homeostasis	2	3.72	1.00e-03	3.03e-03	15|248|88|3527	PF00041;PF00082;PF00249;PF00397;PF00435;PF00452;PF00514;PF01336;PF01391;PF02023;PF02037;PF07679;PF08246;PF12796;PF13857
Group	GO:0044265	cellular macromolecule catabolic process	2	3.48	1.12e-03	3.32e-03	25|248|187|3527	PF00082;PF00098;PF00134;PF00179;PF00226;PF00240;PF00397;PF00400;PF00452;PF00622;PF00643;PF00789;PF01909;PF02148;PF02214;PF02825;PF02845;PF03256;PF03828;PF07707;PF12895;PF13589;PF13638;PF13646;PF13920
Group	GO:0010942	positive regulation of cell death	2	3.59	1.13e-03	3.35e-03	18|248|117|3527	PF00019;PF00041;PF00090;PF00169;PF00240;PF00397;PF00452;PF00514;PF00643;PF00688;PF01335;PF01391;PF01585;PF07653;PF07679;PF08246;PF10409;PF13716
Group	GO:0017038	protein import	2	3.76	1.18e-03	3.49e-03	12|248|63|3527	PF00019;PF00226;PF00400;PF00514;PF00688;PF02064;PF02145;PF03810;PF04695;PF07645;PF12796;PF13513
Group	GO:0043244	regulation of protein complex disassembly	2	4.11	1.25e-03	3.61e-03	7|248|25|3527	PF00041;PF00241;PF00435;PF00514;PF00622;PF00643;PF12348
Group	GO:0032970	regulation of actin filament-based process	2	3.79	1.24e-03	3.61e-03	11|248|55|3527	PF00041;PF00130;PF00169;PF00241;PF00400;PF00610;PF00611;PF00786;PF02181;PF07653;PF12796
Group	GO:0045596	negative regulation of cell differentiation	2	3.55	1.25e-03	3.61e-03	18|248|118|3527	PF00019;PF00098;PF00249;PF00514;PF00688;PF00778;PF00780;PF01064;PF01391;PF01403;PF01417;PF02177;PF03165;PF07645;PF07679;PF12796;PF12924;PF13716
Group	GO:0071495	cellular response to endogenous stimulus	2	3.52	1.29e-03	3.61e-03	19|248|128|3527	PF00019;PF00041;PF00049;PF00093;PF00102;PF00169;PF00249;PF00452;PF00640;PF00688;PF00757;PF01030;PF01064;PF01179;PF01391;PF07653;PF07679;PF10409;PF13855
Group	GO:0016331	morphogenesis of embryonic epithelium	2	3.70	1.36e-03	3.68e-03	12|248|64|3527	PF00096;PF00130;PF00625;PF00786;PF01064;PF01843;PF02145;PF02185;PF02828;PF07653;PF07679;PF12796
Group	GO:0002252	immune effector process	2	3.52	1.60e-03	4.24e-03	15|248|92|3527	PF00041;PF00057;PF00090;PF00102;PF00130;PF00969;PF01391;PF01909;PF04055;PF07645;PF07679;PF08246;PF10409;PF10421;PF13855
Group	GO:0050919	negative chemotaxis	2	4.21	1.95e-03	5.05e-03	5|248|14|3527	PF00341;PF01403;PF01462;PF02210;PF13855
Group	GO:0033365	protein localization to organelle	2	3.39	1.99e-03	5.12e-03	17|248|113|3527	PF00019;PF00025;PF00226;PF00240;PF00350;PF00397;PF00435;PF00514;PF00688;PF02064;PF02145;PF03810;PF04695;PF07645;PF08389;PF12796;PF13513
Group	GO:0000279	M phase	2	3.34	2.04e-03	5.25e-03	19|248|133|3527	PF00130;PF00179;PF00240;PF00400;PF00651;PF00780;PF02148;PF07679;PF07707;PF08393;PF12348;PF12775;PF12780;PF12796;PF12895;PF13091;PF13589;PF13857;PF13964
Group	GO:0060173	limb development	2	3.59	2.46e-03	6.13e-03	9|248|43|3527	PF00019;PF00057;PF00096;PF00452;PF00688;PF01448;PF03165;PF07679;PF07719
Group	GO:0048678	response to axon injury	2	3.99	2.76e-03	6.70e-03	5|248|15|3527	PF00041;PF00452;PF07645;PF07679;PF13855
Group	GO:0045927	positive regulation of growth	2	3.39	2.97e-03	7.19e-03	11|248|61|3527	PF00125;PF00133;PF00169;PF00612;PF00757;PF00989;PF01030;PF01064;PF03165;PF12796;PF13716
Group	GO:0051325	interphase	2	3.34	3.02e-03	7.28e-03	12|248|70|3527	PF00019;PF00096;PF00134;PF00452;PF00581;PF00688;PF01336;PF01833;PF02037;PF02177;PF12924;PF14324
Group	GO:0051046	regulation of secretion	2	3.25	3.05e-03	7.28e-03	15|248|98|3527	PF00019;PF00027;PF00040;PF00169;PF00610;PF00618;PF00622;PF00688;PF00969;PF01064;PF01833;PF02214;PF02931;PF04055;PF04144
Group	GO:0050865	regulation of cell activation	2	3.26	3.35e-03	7.84e-03	13|248|80|3527	PF00019;PF00041;PF00096;PF00102;PF00130;PF00341;PF00594;PF00611;PF00651;PF00688;PF00969;PF05790;PF07653
Group	GO:0043122	regulation of I-kappaB kinase/NF-kappaB cascade	2	3.42	3.42e-03	7.98e-03	9|248|45|3527	PF00122;PF00179;PF00240;PF00689;PF00690;PF00702;PF01391;PF12796;PF13920
Group	GO:0016055	Wnt receptor signaling pathway	2	3.40	4.10e-03	9.21e-03	8|248|38|3527	PF00049;PF00057;PF00435;PF00514;PF00610;PF00778;PF02377;PF07707
Group	GO:0034220	ion transmembrane transport	2	3.21	4.38e-03	9.76e-03	11|248|64|3527	PF00027;PF00122;PF00153;PF00452;PF00622;PF00690;PF00702;PF01699;PF02214;PF12796;PF13426
Group	GO:0045892	negative regulation of transcription, DNA-dependent	2	3.02	4.46e-03	9.92e-03	18|248|132|3527	PF00096;PF00125;PF00179;PF00389;PF00400;PF00514;PF00651;PF00688;PF01448;PF01585;PF02201;PF02826;PF05033;PF07679;PF12796;PF13415;PF13854;PF13920
Group	GO:0007601	visual perception	3	8.39	6.24e-09	7.57e-08	13|248|27|3527	PF00027;PF00053;PF00055;PF00106;PF00350;PF00415;PF00612;PF00625;PF02931;PF03607;PF07719;PF13385;PF13857
Group	GO:0050920	regulation of chemotaxis	3	7.42	5.38e-07	4.57e-06	9|248|17|3527	PF00019;PF00341;PF00625;PF00688;PF01403;PF01437;PF01833;PF02210;PF07653
Group	GO:0051897	positive regulation of protein kinase B signaling cascade	3	7.35	1.11e-06	8.45e-06	8|248|14|3527	PF00019;PF00049;PF00594;PF00688;PF00757;PF01030;PF07653;PF12763
Group	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	3	6.74	4.20e-06	2.76e-05	8|248|16|3527	PF00019;PF00041;PF00049;PF00169;PF00341;PF00688;PF07653;PF07679
Group	GO:0009648	photoperiodism	3	7.01	8.00e-06	4.89e-05	6|248|9|3527	PF00076;PF00098;PF00249;PF00400;PF00989;PF08447
Group	GO:0045822	negative regulation of heart contraction	3	7.32	9.36e-06	5.58e-05	5|248|6|3527	PF00122;PF00169;PF00689;PF00690;PF00702
Group	GO:0007254	JNK cascade	3	6.22	1.26e-05	7.31e-05	8|248|18|3527	PF00049;PF00240;PF00625;PF00640;PF00780;PF00786;PF01843;PF07653
Group	GO:0045834	positive regulation of lipid metabolic process	3	5.80	1.50e-05	8.63e-05	10|248|29|3527	PF00019;PF00041;PF00049;PF00169;PF00341;PF00688;PF01391;PF07653;PF07679;PF12697
Group	GO:0031345	negative regulation of cell projection organization	3	5.99	2.05e-05	1.11e-04	8|248|19|3527	PF00041;PF00096;PF00254;PF00780;PF01403;PF01462;PF02210;PF13855
Group	GO:0048840	otolith development	3	7.28	2.39e-05	1.26e-04	4|248|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0032472	Golgi calcium ion transport	3	7.28	2.39e-05	1.26e-04	4|248|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0032468	Golgi calcium ion homeostasis	3	7.28	2.39e-05	1.26e-04	4|248|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0035147	branch fusion, open tracheal system	3	6.67	3.09e-05	1.57e-04	5|248|7|3527	PF00435;PF00625;PF07653;PF08447;PF13855
Group	GO:0002026	regulation of the force of heart contraction	3	6.17	3.90e-05	1.93e-04	6|248|11|3527	PF00122;PF00169;PF00689;PF00690;PF00702;PF01699
Group	GO:0048640	negative regulation of developmental growth	3	6.17	3.90e-05	1.93e-04	6|248|11|3527	PF00019;PF00611;PF00622;PF00688;PF01403;PF02210
Group	GO:0040023	establishment of nucleus localization	3	5.58	4.86e-05	2.35e-04	8|248|21|3527	PF00130;PF00435;PF00780;PF07728;PF08393;PF12774;PF12775;PF12780
Group	GO:0002028	regulation of sodium ion transport	3	5.76	5.16e-05	2.45e-04	7|248|16|3527	PF00122;PF00169;PF00397;PF00435;PF00689;PF00690;PF00702
Group	GO:0042462	eye photoreceptor cell development	3	5.76	5.16e-05	2.45e-04	7|248|16|3527	PF00096;PF00415;PF00612;PF00651;PF02210;PF03607;PF10409
Group	GO:0010594	regulation of endothelial cell migration	3	6.14	7.76e-05	3.44e-04	5|248|8|3527	PF00019;PF00102;PF00130;PF00341;PF00688
Group	GO:0036058	filtration diaphragm assembly	3	6.14	7.76e-05	3.44e-04	5|248|8|3527	PF00041;PF00102;PF00625;PF07653;PF07679
Group	GO:0060972	left/right pattern formation	3	6.14	7.76e-05	3.44e-04	5|248|8|3527	PF00400;PF00612;PF05033;PF12796;PF13857
Group	GO:0033135	regulation of peptidyl-serine phosphorylation	3	6.14	7.76e-05	3.44e-04	5|248|8|3527	PF00019;PF00169;PF00452;PF00688;PF00786
Group	GO:0042552	myelination	3	5.22	7.67e-05	3.44e-04	9|248|28|3527	PF00041;PF00169;PF00200;PF00612;PF01421;PF02023;PF07679;PF08516;PF13716
Group	GO:0055071	manganese ion homeostasis	3	6.39	1.13e-04	4.79e-04	4|248|5|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0051238	sequestering of metal ion	3	6.39	1.13e-04	4.79e-04	4|248|5|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0035265	organ growth	3	5.53	1.28e-04	5.27e-04	6|248|13|3527	PF00019;PF00688;PF02037;PF07679;PF12796;PF14324
Group	GO:0007179	transforming growth factor beta receptor signaling pathway	3	5.53	1.28e-04	5.27e-04	6|248|13|3527	PF00106;PF00341;PF00683;PF01064;PF07645;PF12874
Group	GO:0008542	visual learning	3	5.53	1.28e-04	5.27e-04	6|248|13|3527	PF00122;PF00689;PF00690;PF00702;PF02177;PF12924
Group	GO:0022405	hair cycle process	3	5.30	1.27e-04	5.27e-04	7|248|18|3527	PF00019;PF00688;PF00757;PF01030;PF01391;PF02210;PF07679
Group	GO:0018209	peptidyl-serine modification	3	5.30	1.27e-04	5.27e-04	7|248|18|3527	PF00130;PF00169;PF00341;PF01462;PF02210;PF03062;PF13855
Group	GO:0017145	stem cell division	3	5.06	1.46e-04	5.85e-04	8|248|24|3527	PF00019;PF00076;PF00096;PF00130;PF00640;PF00688;PF01064;PF03165
Group	GO:0016339	calcium-dependent cell-cell adhesion	3	5.70	1.65e-04	6.46e-04	5|248|9|3527	PF00122;PF00689;PF00690;PF00702;PF02210
Group	GO:0045186	zonula adherens assembly	3	5.70	1.65e-04	6.46e-04	5|248|9|3527	PF00130;PF00169;PF00435;PF02828;PF07653
Group	GO:0048009	insulin-like growth factor receptor signaling pathway	3	5.70	1.65e-04	6.46e-04	5|248|9|3527	PF00049;PF00169;PF00757;PF01030;PF02145
Group	GO:0001666	response to hypoxia	3	4.60	1.97e-04	7.63e-04	11|248|45|3527	PF00019;PF00045;PF00341;PF00413;PF00643;PF00688;PF00989;PF02145;PF02931;PF08447;PF13716
Group	GO:0008358	maternal determination of anterior/posterior axis, embryo	3	5.25	2.11e-04	8.10e-04	6|248|14|3527	PF00076;PF00622;PF00651;PF01064;PF07525;PF13091
Group	GO:0002118	aggressive behavior	3	5.25	2.11e-04	8.10e-04	6|248|14|3527	PF00076;PF00096;PF00651;PF00970;PF01369;PF13855
Group	GO:0045667	regulation of osteoblast differentiation	3	4.91	2.74e-04	1.01e-03	7|248|20|3527	PF00019;PF00093;PF00514;PF00688;PF01064;PF03165;PF07645
Group	GO:0051017	actin filament bundle assembly	3	4.75	2.74e-04	1.01e-03	8|248|26|3527	PF00611;PF00612;PF02181;PF02214;PF06367;PF06371;PF07653;PF12796
Group	GO:0035001	dorsal trunk growth, open tracheal system	3	5.72	3.20e-04	1.15e-03	4|248|6|3527	PF00057;PF00625;PF02828;PF07653
Group	GO:0006275	regulation of DNA replication	3	4.48	4.82e-04	1.68e-03	8|248|28|3527	PF00019;PF00134;PF00341;PF00688;PF01336;PF12171;PF12756;PF12895
Group	GO:0070167	regulation of biomineral tissue development	3	4.78	5.00e-04	1.70e-03	6|248|16|3527	PF00019;PF00594;PF00688;PF01064;PF02210;PF07645
Group	GO:0006509	membrane protein ectodomain proteolysis	3	4.78	5.00e-04	1.70e-03	6|248|16|3527	PF00076;PF00200;PF00612;PF01421;PF02225;PF08516
Group	GO:1901185	negative regulation of ERBB signaling pathway	3	4.78	5.00e-04	1.70e-03	6|248|16|3527	PF00041;PF01448;PF01585;PF07525;PF07679;PF13855
Group	GO:0045444	fat cell differentiation	3	4.78	5.00e-04	1.70e-03	6|248|16|3527	PF00019;PF00249;PF00389;PF00688;PF01391;PF02826
Group	GO:0032292	peripheral nervous system axon ensheathment	3	4.99	5.37e-04	1.78e-03	5|248|11|3527	PF00169;PF00200;PF01421;PF08516;PF13716
Group	GO:0032321	positive regulation of Rho GTPase activity	3	4.99	5.37e-04	1.78e-03	5|248|11|3527	PF00041;PF00611;PF00612;PF06920;PF14429
Group	GO:0008586	imaginal disc-derived wing vein morphogenesis	3	4.99	5.37e-04	1.78e-03	5|248|11|3527	PF00397;PF00612;PF01400;PF01448;PF07645
Group	GO:0001892	embryonic placenta development	3	4.56	5.33e-04	1.78e-03	7|248|22|3527	PF00169;PF00341;PF00757;PF00989;PF01030;PF07679;PF08447
Group	GO:0060491	regulation of cell projection assembly	3	4.56	5.33e-04	1.78e-03	7|248|22|3527	PF00130;PF00612;PF00786;PF02181;PF06367;PF06371;PF12796
Group	GO:0007623	circadian rhythm	3	4.35	6.25e-04	2.02e-03	8|248|29|3527	PF00027;PF00076;PF00098;PF00249;PF00583;PF00989;PF08447;PF13716
Group	GO:0010770	positive regulation of cell morphogenesis involved in differentiation	3	5.19	7.05e-04	2.22e-03	4|248|7|3527	PF00019;PF00514;PF00688;PF03165
Group	GO:0051291	protein heterooligomerization	3	5.19	7.05e-04	2.22e-03	4|248|7|3527	PF00041;PF00757;PF01030;PF01391
Group	GO:0070050	neuron homeostasis	3	5.19	7.05e-04	2.22e-03	4|248|7|3527	PF00041;PF07679;PF12796;PF13857
Group	GO:0040035	hermaphrodite genitalia development	3	5.19	7.05e-04	2.22e-03	4|248|7|3527	PF00076;PF00125;PF00134;PF00400
Group	GO:0006828	manganese ion transport	3	5.19	7.05e-04	2.22e-03	4|248|7|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0007309	oocyte axis specification	3	4.57	7.27e-04	2.24e-03	6|248|17|3527	PF00076;PF00130;PF00622;PF00651;PF07525;PF13091
Group	GO:0007173	epidermal growth factor receptor signaling pathway	3	4.40	7.21e-04	2.24e-03	7|248|23|3527	PF00019;PF00130;PF00169;PF00688;PF00757;PF01030;PF07645
Group	GO:0016525	negative regulation of angiogenesis	3	4.40	7.21e-04	2.24e-03	7|248|23|3527	PF00041;PF00090;PF00093;PF00102;PF00643;PF07645;PF12947
Group	GO:0001935	endothelial cell proliferation	3	4.70	8.68e-04	2.65e-03	5|248|12|3527	PF00019;PF00625;PF00688;PF05485;PF07653
Group	GO:0007435	salivary gland morphogenesis	3	4.38	1.03e-03	3.07e-03	6|248|18|3527	PF00102;PF00514;PF01391;PF01403;PF07679;PF10409
Group	GO:0006029	proteoglycan metabolic process	3	4.38	1.03e-03	3.07e-03	6|248|18|3527	PF00049;PF01462;PF02210;PF02709;PF13733;PF13855
Group	GO:0045807	positive regulation of endocytosis	3	4.38	1.03e-03	3.07e-03	6|248|18|3527	PF00341;PF00397;PF00400;PF00594;PF01391;PF02210
Group	GO:0070734	histone H3-K27 methylation	3	5.32	1.30e-03	3.61e-03	3|248|4|3527	PF05033;PF12796;PF13857
Group	GO:0045196	establishment or maintenance of neuroblast polarity	3	4.76	1.33e-03	3.61e-03	4|248|8|3527	PF00130;PF00625;PF02828;PF07653
Group	GO:0009624	response to nematode	3	4.76	1.33e-03	3.61e-03	4|248|8|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0010717	regulation of epithelial to mesenchymal transition	3	4.76	1.33e-03	3.61e-03	4|248|8|3527	PF00019;PF00514;PF00688;PF03165
Group	GO:0034121	regulation of toll-like receptor signaling pathway	3	4.76	1.33e-03	3.61e-03	4|248|8|3527	PF00041;PF04055;PF07679;PF12796
Group	GO:0050772	positive regulation of axonogenesis	3	4.76	1.33e-03	3.61e-03	4|248|8|3527	PF01403;PF01437;PF07679;PF13855
Group	GO:0050918	positive chemotaxis	3	4.76	1.33e-03	3.61e-03	4|248|8|3527	PF00019;PF00341;PF00688;PF02145
Group	GO:0016332	establishment or maintenance of polarity of embryonic epithelium	3	4.76	1.33e-03	3.61e-03	4|248|8|3527	PF00130;PF00625;PF02828;PF07653
Group	GO:0060761	negative regulation of response to cytokine stimulus	3	4.76	1.33e-03	3.61e-03	4|248|8|3527	PF00041;PF00102;PF01391;PF02210
Group	GO:0000186	activation of MAPKK activity	3	4.76	1.33e-03	3.61e-03	4|248|8|3527	PF00019;PF00688;PF00780;PF07653
Group	GO:0007520	myoblast fusion	3	4.44	1.33e-03	3.61e-03	5|248|13|3527	PF00041;PF01369;PF06920;PF07679;PF12796
Group	GO:0050852	T cell receptor signaling pathway	3	4.44	1.33e-03	3.61e-03	5|248|13|3527	PF00041;PF00388;PF00625;PF00969;PF09279
Group	GO:0006984	ER-nucleus signaling pathway	3	4.11	1.25e-03	3.61e-03	7|248|25|3527	PF00049;PF00122;PF00226;PF00400;PF00689;PF00690;PF00702
Group	GO:0006911	phagocytosis, engulfment	3	4.20	1.41e-03	3.76e-03	6|248|19|3527	PF00102;PF00106;PF00200;PF00249;PF01217;PF01448
Group	GO:0009636	response to toxin	3	4.20	1.41e-03	3.76e-03	6|248|19|3527	PF00122;PF00452;PF00702;PF00989;PF02931;PF08447
Group	GO:0021536	diencephalon development	3	4.20	1.41e-03	3.76e-03	6|248|19|3527	PF00019;PF00096;PF00249;PF00688;PF01064;PF07679
Group	GO:0042476	odontogenesis	3	4.20	1.41e-03	3.76e-03	6|248|19|3527	PF00019;PF00096;PF00688;PF01064;PF01391;PF07679
Group	GO:0007050	cell cycle arrest	3	4.20	1.41e-03	3.76e-03	6|248|19|3527	PF00019;PF00350;PF00397;PF00640;PF00688;PF07645
Group	GO:0006885	regulation of pH	3	4.03	1.90e-03	5.02e-03	6|248|20|3527	PF00122;PF00400;PF00689;PF00690;PF00702;PF01496
Group	GO:0034332	adherens junction organization	3	4.21	1.95e-03	5.05e-03	5|248|14|3527	PF00514;PF00625;PF00640;PF07653;PF07679
Group	GO:0060968	regulation of gene silencing	3	4.21	1.95e-03	5.05e-03	5|248|14|3527	PF00076;PF00096;PF00651;PF01448;PF08210
Group	GO:0014037	Schwann cell differentiation	3	4.21	1.95e-03	5.05e-03	5|248|14|3527	PF00169;PF00200;PF01421;PF08516;PF13716
Group	GO:0048771	tissue remodeling	3	4.21	1.95e-03	5.05e-03	5|248|14|3527	PF00049;PF00082;PF00452;PF00688;PF01064
Group	GO:0007266	Rho protein signal transduction	3	4.21	1.95e-03	5.05e-03	5|248|14|3527	PF00169;PF00435;PF00612;PF00651;PF02185
Group	GO:0060571	morphogenesis of an epithelial fold	3	4.39	2.27e-03	5.66e-03	4|248|9|3527	PF00130;PF00757;PF01030;PF07679
Group	GO:0002040	sprouting angiogenesis	3	4.39	2.27e-03	5.66e-03	4|248|9|3527	PF00019;PF00341;PF00688;PF12796
Group	GO:0006611	protein export from nucleus	3	4.39	2.27e-03	5.66e-03	4|248|9|3527	PF00019;PF00688;PF03810;PF08389
Group	GO:0001751	compound eye photoreceptor cell differentiation	3	4.39	2.27e-03	5.66e-03	4|248|9|3527	PF00096;PF00612;PF00651;PF10409
Group	GO:0007176	regulation of epidermal growth factor-activated receptor activity	3	4.39	2.27e-03	5.66e-03	4|248|9|3527	PF01585;PF02177;PF07525;PF12924
Group	GO:0010821	regulation of mitochondrion organization	3	4.39	2.27e-03	5.66e-03	4|248|9|3527	PF00049;PF00169;PF00452;PF12906
Group	GO:0060428	lung epithelium development	3	4.39	2.27e-03	5.66e-03	4|248|9|3527	PF00049;PF00640;PF03165;PF07679
Group	GO:0050806	positive regulation of synaptic transmission	3	4.39	2.27e-03	5.66e-03	4|248|9|3527	PF01699;PF02210;PF07679;PF13855
Group	GO:0001569	patterning of blood vessels	3	4.39	2.27e-03	5.66e-03	4|248|9|3527	PF00090;PF00341;PF01403;PF01437
Group	GO:0009069	serine family amino acid metabolic process	3	3.87	2.51e-03	6.23e-03	6|248|21|3527	PF00389;PF00586;PF01571;PF01597;PF02769;PF02826
Group	GO:0030522	intracellular receptor mediated signaling pathway	3	3.73	2.57e-03	6.33e-03	7|248|28|3527	PF00076;PF00226;PF00643;PF00684;PF00989;PF08447;PF13426
Group	GO:0007093	mitotic cell cycle checkpoint	3	3.73	2.57e-03	6.33e-03	7|248|28|3527	PF00019;PF00134;PF00452;PF00688;PF02037;PF12796;PF14324
Group	GO:0010827	regulation of glucose transport	3	3.99	2.76e-03	6.70e-03	5|248|15|3527	PF00049;PF00130;PF00169;PF01391;PF12796
Group	GO:0043112	receptor metabolic process	3	3.99	2.76e-03	6.70e-03	5|248|15|3527	PF00019;PF00082;PF00169;PF00397;PF00688
Group	GO:0060840	artery development	3	3.99	2.76e-03	6.70e-03	5|248|15|3527	PF00019;PF00106;PF00688;PF01064;PF13716
Group	GO:0061318	renal filtration cell differentiation	3	3.99	2.76e-03	6.70e-03	5|248|15|3527	PF00041;PF00102;PF00200;PF00612;PF07679
Group	GO:0045161	neuronal ion channel clustering	3	4.64	3.09e-03	7.28e-03	3|248|5|3527	PF00041;PF00435;PF07679
Group	GO:0022416	chaeta development	3	4.64	3.09e-03	7.28e-03	3|248|5|3527	PF00076;PF00625;PF07653
Group	GO:0070206	protein trimerization	3	4.64	3.09e-03	7.28e-03	3|248|5|3527	PF00622;PF00643;PF01391
Group	GO:0048036	central complex development	3	4.64	3.09e-03	7.28e-03	3|248|5|3527	PF00041;PF00102;PF07679
Group	GO:0060363	cranial suture morphogenesis	3	4.64	3.09e-03	7.28e-03	3|248|5|3527	PF00019;PF00688;PF07679
Group	GO:0060021	palate development	3	3.72	3.25e-03	7.64e-03	6|248|22|3527	PF00019;PF00096;PF00688;PF01064;PF03165;PF07719
Group	GO:0051645	Golgi localization	3	4.08	3.57e-03	8.19e-03	4|248|10|3527	PF00388;PF00612;PF01843;PF09279
Group	GO:0060026	convergent extension	3	4.08	3.57e-03	8.19e-03	4|248|10|3527	PF00610;PF00778;PF02377;PF06297
Group	GO:0045778	positive regulation of ossification	3	4.08	3.57e-03	8.19e-03	4|248|10|3527	PF00019;PF00688;PF01064;PF07645
Group	GO:0051567	histone H3-K9 methylation	3	4.08	3.57e-03	8.19e-03	4|248|10|3527	PF00134;PF05033;PF12796;PF13857
Group	GO:0051784	negative regulation of nuclear division	3	4.08	3.57e-03	8.19e-03	4|248|10|3527	PF00019;PF00688;PF02148;PF07679
Group	GO:0042036	negative regulation of cytokine biosynthetic process	3	4.08	3.57e-03	8.19e-03	4|248|10|3527	PF00019;PF00076;PF00688;PF12796
Group	GO:0010464	regulation of mesenchymal cell proliferation	3	3.80	3.79e-03	8.57e-03	5|248|16|3527	PF00019;PF00341;PF00688;PF03165;PF07679
Group	GO:0006937	regulation of muscle contraction	3	3.80	3.79e-03	8.57e-03	5|248|16|3527	PF00122;PF00689;PF00690;PF00702;PF02931
Group	GO:0046331	lateral inhibition	3	3.80	3.79e-03	8.57e-03	5|248|16|3527	PF00130;PF00625;PF01465;PF02828;PF07653
Group	GO:0035150	regulation of tube size	3	3.80	3.79e-03	8.57e-03	5|248|16|3527	PF00057;PF00625;PF02828;PF07653;PF13903
Group	GO:0042752	regulation of circadian rhythm	3	3.80	3.79e-03	8.57e-03	5|248|16|3527	PF00027;PF00076;PF00098;PF00989;PF08447
Group	GO:0021782	glial cell development	3	3.51	3.91e-03	8.82e-03	7|248|30|3527	PF00169;PF00200;PF01421;PF07679;PF08516;PF13716;PF13903
Group	GO:0042157	lipoprotein metabolic process	3	3.59	4.15e-03	9.27e-03	6|248|23|3527	PF00025;PF00057;PF03062;PF07645;PF10277;PF12796
Group	GO:0030336	negative regulation of cell migration	3	3.59	4.15e-03	9.27e-03	6|248|23|3527	PF00019;PF00102;PF00688;PF01391;PF10409;PF13855
Group	GO:0010256	endomembrane system organization	4	6.30	3.44e-04	1.22e-03	3|248|3|3527	PF01369;PF09324;PF12783
Group	GO:0060971	embryonic heart tube left/right pattern formation	4	6.30	3.44e-04	1.22e-03	3|248|3|3527	PF00612;PF12796;PF13857
Group	GO:0008053	mitochondrial fusion	4	5.32	1.30e-03	3.61e-03	3|248|4|3527	PF00350;PF00452;PF13091
Group	GO:0033138	positive regulation of peptidyl-serine phosphorylation	4	5.32	1.30e-03	3.61e-03	3|248|4|3527	PF00019;PF00688;PF00786
Group	GO:0034122	negative regulation of toll-like receptor signaling pathway	4	5.32	1.30e-03	3.61e-03	3|248|4|3527	PF00041;PF07679;PF12796
Group	GO:0018095	protein polyglutamylation	4	5.32	1.30e-03	3.61e-03	3|248|4|3527	PF00581;PF03133;PF07719
Group	GO:0007183	SMAD protein complex assembly	4	5.32	1.30e-03	3.61e-03	3|248|4|3527	PF00019;PF00688;PF03165
Group	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	4	5.32	1.30e-03	3.61e-03	3|248|4|3527	PF00019;PF00688;PF01064
Group	GO:0040010	positive regulation of growth rate	4	4.64	3.09e-03	7.28e-03	3|248|5|3527	PF00125;PF00133;PF00989
Group	GO:0045648	positive regulation of erythrocyte differentiation	4	4.64	3.09e-03	7.28e-03	3|248|5|3527	PF00019;PF00688;PF12796
